<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE book-part-wrapper PUBLIC "-//NLM//DTD BITS Book Interchange DTD v2.0 20151225//EN" "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
<book-part-wrapper id="col4a1-dis" content-type="chapter" from-where="body" dtd-version="2.0">
  <book-meta>
    <book-id book-id-type="pmcid">gene</book-id>
    <book-title-group>
      <book-title>GeneReviews<sup>&#x000ae;</sup></book-title>
    </book-title-group>
    <contrib-group>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Adam</surname>
          <given-names>Margaret P</given-names>
        </name>
        <role>Editor-in-Chief</role>
      </contrib>
    </contrib-group>
    <contrib-group>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Ardinger</surname>
          <given-names>Holly H</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Pagon</surname>
          <given-names>Roberta A</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Wallace</surname>
          <given-names>Stephanie E</given-names>
        </name>
      </contrib>
      <role>Senior Editors</role>
    </contrib-group>
    <contrib-group>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Bean</surname>
          <given-names>Lora JH</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Mefford</surname>
          <given-names>Heather C</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Stephens</surname>
          <given-names>Karen</given-names>
        </name>
      </contrib>
      <role>Molecular Genetics</role>
    </contrib-group>
    <contrib-group>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Amemiya</surname>
          <given-names>Anne</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Ledbetter</surname>
          <given-names>Nikki</given-names>
        </name>
      </contrib>
      <role>Genetic Counseling</role>
    </contrib-group>
    <pub-date publication-format="electronic" date-type="pubr">
      <year>1993</year>
    </pub-date>
    <pub-date publication-format="electronic" date-type="pubr">
      <year>2017</year>
    </pub-date>
    <issn>2372-0697</issn>
    <publisher>
      <publisher-name>University of Washington, Seattle</publisher-name>
      <publisher-loc>Seattle (WA)</publisher-loc>
    </publisher>
    <permissions>
      <copyright-statement>Copyright &#x000a9; 1993-2017, University of Washington, Seattle. GeneReviews is a registered trademark of the University of Washington, Seattle. All rights reserved.</copyright-statement>
      <copyright-year>2017</copyright-year>
      <license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="https://www.ncbi.nlm.nih.gov/books/NBK138602/">
        <license-p>GeneReviews&#x000ae; chapters are owned by the University of Washington. Permission is hereby granted to reproduce, distribute, and translate copies of content materials for noncommercial research purposes only, provided that (i) credit for source (<ext-link ext-link-type="uri" xlink:href="http://www.genereviews.org/">http://www.genereviews.org/</ext-link>) and copyright (&#x000a9; 1993-2017 University of Washington) are included with each copy; (ii) a link to the original material is provided whenever the material is published elsewhere on the Web; and (iii) reproducers, distributors, and/or translators comply with the <related-object source-id="gene" document-id="GRcopyright_permiss">GeneReviews&#x000ae; Copyright Notice and Usage Disclaimer</related-object>. No further modifications are allowed. For clarity, excerpts of GeneReviews chapters for use in lab reports and clinic notes are a permitted use.</license-p>
        <license-p>For more information, see the <related-object source-id="gene" document-id="GRcopyright_permiss">GeneReviews&#x000ae; Copyright Notice and Usage Disclaimer</related-object>.</license-p>
        <license-p>For questions regarding permissions or whether a specified use is allowed, contact: <email>admasst@uw.edu</email>.</license-p>
      </license>
    </permissions>
    <custom-meta-group>
      <custom-meta>
        <meta-name>books-subject</meta-name>
        <meta-value>Genetics</meta-value>
      </custom-meta>
      <custom-meta>
        <meta-name>books-subject</meta-name>
        <meta-value>Medicine</meta-value>
      </custom-meta>
      <custom-meta>
        <meta-name>books-subject</meta-name>
        <meta-value>Diseases</meta-value>
      </custom-meta>
      <custom-meta>
        <meta-name>books-source-type</meta-name>
        <meta-value>Database</meta-value>
      </custom-meta>
    </custom-meta-group>
    <notes notes-type="ednotes">
      <p content-type="genetic_counseling">
<italic toggle="yes">Genetic counseling is the process of
providing individuals and families with information on the nature, inheritance,
and implications of genetic disorders to help them make informed medical and
personal decisions. The following section deals with genetic risk assessment and
the use of family history and genetic testing to clarify genetic status for
family members. This section is not meant to address all personal, cultural, or
ethical issues that individuals may face or to substitute for consultation with
a genetics professional</italic>. &#x02014;ED.</p>
      <p content-type="resources">
<italic toggle="yes">GeneReviews staff has selected the following disease-specific and/or
umbrella support organizations and/or registries for the benefit of individuals
with this disorder and their families. GeneReviews is not responsible for the
information provided by other organizations. For information on selection
criteria, click <related-object source-id="gene" document-id="app4">here</related-object>.</italic></p>
    </notes>
  </book-meta>
  <book-part book-part-type="chapter">
    <book-part-meta>
      <book-part-id book-part-id-type="pmcid">col4a1-dis</book-part-id>
      <title-group>
        <title>
<italic toggle="yes">COL4A1</italic>-Related Disorders</title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Plaisier</surname>
            <given-names>Emmanuelle</given-names>
          </name>
          <degrees>MD, PhD</degrees>
          <aff>Department of Nephrology and Dialysis INSERM UMR S1155<break/>H&#x000f4;pital Tenon<break/>Universit&#x000e9; Pierre et Marie Curie<break/>Paris, France</aff>
          <email>emmanuelle.plaisier@aphp.fr</email>
        </contrib>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Ronco</surname>
            <given-names>Pierre</given-names>
          </name>
          <degrees>MD, PhD</degrees>
          <aff>Department of Nephrology and Dialysis INSERM UMR S1155<break/>H&#x000f4;pital Tenon<break/>Universit&#x000e9; Pierre et Marie Curie<break/>Paris, France</aff>
          <email>pierreronco@yahoo.fr</email>
        </contrib>
      </contrib-group>
      <pub-history>
        <date iso-8601-date="2009-06-25" date-type="created">
          <day>25</day>
          <month>6</month>
          <year>2009</year>
        </date>
        <date iso-8601-date="2016-07-07" date-type="updated">
          <day>7</day>
          <month>7</month>
          <year>2016</year>
        </date>
      </pub-history>
      <related-object link-type="parent-book-link" source-id="gene">GeneReviews<sup>&#x000ae;</sup></related-object>
      <related-object link-type="previous-part-link" source-id="gene" document-id="oi" document-type="chapter"><italic toggle="yes">COL1A1/2</italic>-Related Osteogenesis Imperfecta</related-object>
      <related-object link-type="next-part-link" source-id="gene" document-id="caffey" document-type="chapter">Caffey Disease</related-object>
      <abstract id="col4a1-dis.Summary">
        <title>Summary</title>
        <sec>
          <title>Clinical characteristics</title>
          <p>The spectrum of <italic toggle="yes">COL4A1</italic>-related disorders includes: small-vessel brain disease of varying severity including porencephaly, variably associated with eye defects (retinal arterial tortuosity, Axenfeld-Rieger anomaly, cataract) and systemic findings (kidney involvement, muscle cramps, cerebral aneurysms, Raynaud phenomenon, cardiac arrhythmia, and hemolytic anemia). On imaging studies, small-vessel brain disease is manifest as diffuse periventricular leukoencephalopathy, lacunar infarcts, microhemorrhage, dilated perivascular spaces, and deep intracerebral hemorrhages. Clinically, small-vessel brain disease manifests as infantile hemiparesis, seizures, single or recurrent hemorrhagic stroke, ischemic stroke, and isolated migraine with aura. Porencephaly (fluid-filled cavities in the brain detected by CT or MRI) is typically manifest as infantile hemiparesis, seizures, and intellectual disability; however, on occasion it can be an incidental finding. HANAC (<italic toggle="yes">h</italic>ereditary <italic toggle="yes">a</italic>ngiopathy with <italic toggle="yes">n</italic>ephropathy, <italic toggle="yes">a</italic>neurysms, and muscle <italic toggle="yes">c</italic>ramps) syndrome usually associates asymptomatic small-vessel brain disease, cerebral large vessel involvement (i.e., aneurysms), and systemic findings involving the kidney, muscle, and small vessels of the eye. Two additional phenotypes include isolated retinal artery tortuosity and nonsyndromic autosomal dominant congenital cataract.</p>
        </sec>
        <sec>
          <title>Diagnosis/testing</title>
          <p>Diagnosis is based on clinical findings and molecular genetic testing of <italic toggle="yes">COL4A1</italic>.</p>
        </sec>
        <sec>
          <title>Management</title>
          <p><italic toggle="yes">Treatment of manifestations:</italic> Supportive care tailored to the individual&#x02019;s specific medical needs and including practical help and emotional support for affected individuals and their families. Hypertension should be treated to reduce the overall risk of stroke.</p>
          <p><italic toggle="yes">Prevention of primary and secondary complications:</italic> Avoiding head trauma and anticoagulant exposure may decrease the risk for intracerebral hemorrhage.</p>
          <p><italic toggle="yes">Surveillance:</italic> Depends on the severity and type of symptoms.</p>
          <p><italic toggle="yes">Agents/circumstances to avoid:</italic> Smoking and hypertension because these factors increase the risk for stroke; sustained head pressure or physical activities that may cause head trauma; anticoagulant use.</p>
        </sec>
        <sec>
          <title>Genetic counseling</title>
          <p><italic toggle="yes">COL4A1</italic>-related disorders are inherited in an autosomal dominant manner. Most individuals diagnosed with a <italic toggle="yes">COL4A1</italic>-related disorder have an affected parent. The proportion of cases caused by a <italic toggle="yes">de novo</italic> pathogenic variant is estimated to be at least 27%. Each child of an individual with a <italic toggle="yes">COL4A1</italic>-related disorder has a 50% chance of inheriting the pathogenic variant. Prenatal diagnosis is possible for pregnancies at increased risk if the pathogenic variant in the family is known.</p>
        </sec>
      </abstract>
    </book-part-meta>
    <body>
      <sec id="col4a1-dis.GeneReview_Scope">
        <title><italic toggle="yes">GeneReview</italic> Scope</title>
        <table-wrap id="col4a1-dis.Tc" position="anchor" orientation="portrait">
          <table frame="hsides" rules="groups">
            <thead>
              <tr>
                <th id="hd_h_col4a1-dis.Tc_1_1_1_1" valign="middle" align="left" scope="col" rowspan="1" colspan="1"><italic toggle="yes">COL4A1</italic>-Related Disorders: Included Phenotypes&#x000a0;<sup>1</sup></th>
              </tr>
            </thead>
            <tbody>
              <tr>
                <td headers="hd_h_col4a1-dis.Tc_1_1_1_1" valign="middle" align="left" rowspan="1" colspan="1">
                  <list list-type="bullet">
                    <list-item>
                      <p>Autosomal dominant familial porencephaly</p>
                    </list-item>
                    <list-item>
                      <p>Autosomal dominant brain small-vessel disease with hemorrhage</p>
                    </list-item>
                    <list-item>
                      <p>Hereditary angiopathy with nephropathy, aneurysms, and muscle cramps (HANAC) syndrome</p>
                    </list-item>
                    <list-item>
                      <p>Tortuosity of retinal arteries</p>
                    </list-item>
                    <list-item>
                      <p>Nonsyndromic autosomal dominant congenital cataract</p>
                    </list-item>
                  </list>
                </td>
              </tr>
            </tbody>
          </table>
          <table-wrap-foot>
            <fn id="col4a1-dis.TF.c.1">
              <label>1. </label>
              <p>For other genetic causes of these phenotypes see <xref ref-type="sec" rid="col4a1-dis.Differential_Diagnosis">Differential Diagnosis</xref>.</p>
            </fn>
          </table-wrap-foot>
        </table-wrap>
      </sec>
      <sec id="col4a1-dis.Diagnosis">
        <title>Diagnosis</title>
        <p><italic toggle="yes">COL4A1</italic>-related disorders cover a spectrum of overlapping phenotypes characterized by a small-vessel brain disease of varying severity including porencephaly, variably associated with eye defects (congenital cataract, retinal arterial tortuosity, eye anterior segment anomaly of Axenfeld-Rieger type) and systemic findings (muscle cramps and/or serum creatine kinase (CK) elevation, kidney involvement, cerebral aneurysms, Raynaud phenomenon, cardiac arrhythmia, and hemolytic anemia).</p>
        <sec id="col4a1-dis.Suggestive_Findings">
          <title>Suggestive Findings</title>
          <p>A <italic toggle="yes">COL4A1</italic>-related disorder <bold>should be suspected</bold> in individuals with any of the following phenotypes that have overlapping features:</p>
          <list list-type="bullet">
            <list-item>
              <p>Porencephaly type 1 [<xref ref-type="bibr" rid="col4a1-dis.REF.gould.2005.1167">Gould et al 2005</xref>, <xref ref-type="bibr" rid="col4a1-dis.REF.breedveld.2006.490">Breedveld et al 2006</xref>, <xref ref-type="bibr" rid="col4a1-dis.REF.van_der_knaap.2006.504">van der Knaap et al 2006</xref>, <xref ref-type="bibr" rid="col4a1-dis.REF.yoneda.2013.48">Yoneda et al 2013</xref>, <xref ref-type="bibr" rid="col4a1-dis.REF.meuwissen.2015.843">Meuwissen et al 2015</xref>]</p>
            </list-item>
            <list-item>
              <p>Brain small-vessel disease with or without ocular anomalies [<xref ref-type="bibr" rid="col4a1-dis.REF.gould.2006.1489">Gould et al 2006</xref>, <xref ref-type="bibr" rid="col4a1-dis.REF.sibon.2007.177">Sibon et al 2007</xref>, <xref ref-type="bibr" rid="col4a1-dis.REF.vahedi.2007.1461">Vahedi et al 2007</xref>, <xref ref-type="bibr" rid="col4a1-dis.REF.coupry.2010.483">Coupry et al 2010</xref>, <xref ref-type="bibr" rid="col4a1-dis.REF.shah.2012.569">Shah et al 2012</xref>, <xref ref-type="bibr" rid="col4a1-dis.REF.r_dahl.2013.946">R&#x000f8;dahl et al 2013</xref>, <xref ref-type="bibr" rid="col4a1-dis.REF.meuwissen.2015.843">Meuwissen et al 2015</xref>]</p>
            </list-item>
            <list-item>
              <p>HANAC (<italic toggle="yes">h</italic>ereditary <italic toggle="yes">a</italic>ngiopathy with <italic toggle="yes">n</italic>ephropathy, <italic toggle="yes">a</italic>neurysms, and muscle <italic toggle="yes">c</italic>ramps) syndrome [<xref ref-type="bibr" rid="col4a1-dis.REF.plaisier.2007.2687">Plaisier et al 2007</xref>, <xref ref-type="bibr" rid="col4a1-dis.REF.plaisier.2010.2550">Plaisier et al 2010</xref>]</p>
            </list-item>
            <list-item>
              <p>Tortuosity of retinal arteries [<xref ref-type="bibr" rid="col4a1-dis.REF.zenteno.2014.1789">Zenteno et al 2014</xref>]</p>
            </list-item>
            <list-item>
              <p>Nonsyndromic autosomal dominant congenital cataract [<xref ref-type="bibr" rid="col4a1-dis.REF.xia.2014.97">Xia et al 2014</xref>]</p>
            </list-item>
          </list>
          <p><bold>Clinical features</bold> of <italic toggle="yes">COL4A1</italic>-related disorders vary widely and can include the following:</p>
          <list list-type="bullet">
            <list-item>
              <p>Neurologic</p>
              <list list-type="bullet">
                <list-item>
                  <p>Infantile hemiplegia</p>
                </list-item>
                <list-item>
                  <p>Developmental delay</p>
                </list-item>
                <list-item>
                  <p>Migraines with or without aura</p>
                </list-item>
                <list-item>
                  <p>Seizures</p>
                </list-item>
                <list-item>
                  <p>Dementia</p>
                </list-item>
                <list-item>
                  <p>Intellectual disability</p>
                </list-item>
                <list-item>
                  <p>Intracerebral hemorrhage at any age including antenatal, neonatal, and recurrent episodes</p>
                </list-item>
                <list-item>
                  <p>Ischemic stroke</p>
                </list-item>
                <list-item>
                  <p>Typically on neuroimaging: features of brain small-vessel disease (<xref ref-type="fig" rid="col4a1-dis.F1">Figure 1</xref>)</p>
                </list-item>
              </list>
            </list-item>
            <list-item>
              <p>Ophthalmic</p>
              <list list-type="bullet">
                <list-item>
                  <p>Transient visual loss caused by retinal hemorrhage</p>
                </list-item>
                <list-item>
                  <p>Cataract, glaucoma, microphthalmia/anophthalmia</p>
                </list-item>
              </list>
            </list-item>
            <list-item>
              <p>Other systemic findings</p>
              <list list-type="bullet">
                <list-item>
                  <p>Hematuria</p>
                </list-item>
                <list-item>
                  <p>Raynaud phenomenon</p>
                </list-item>
                <list-item>
                  <p>Supraventricular arrhythmia</p>
                </list-item>
                <list-item>
                  <p>Muscle cramps</p>
                </list-item>
              </list>
            </list-item>
          </list>
          <p><bold>Family history</bold> is consistent with autosomal dominant inheritance. Findings and age of onset vary within and between families.</p>
        </sec>
        <sec id="col4a1-dis.Establishing_the_Diagnosis">
          <title>Establishing the Diagnosis</title>
          <p>The diagnosis of a <italic toggle="yes">COL4A1</italic>-related disorder <bold>is established</bold> in a proband with <xref ref-type="sec" rid="col4a1-dis.Suggestive_Findings">suggestive features</xref> and the identification of a heterozygous pathogenic variant in <italic toggle="yes">COL4A1</italic> (see <xref ref-type="table" rid="col4a1-dis.T.molecular_genetic_testing_u">Table 1</xref>).</p>
          <p>Molecular testing approaches can include <bold>single-gene testing</bold>, use of a <bold>multi-gene panel</bold>, and <bold>more comprehensive</bold>
<bold>genomic testing</bold>.</p>
          <list list-type="bullet">
            <list-item>
              <p><bold>Single-gene testing.</bold> Sequence analysis of <italic toggle="yes">COL4A1</italic> is performed first followed by gene-targeted deletion/duplication analysis if no pathogenic variant is found. To date, no deletions or duplications involving <italic toggle="yes">COL4A1</italic> as causative of <italic toggle="yes">COL4A1</italic>-related disorders have been reported. Because these disorders usually result from a <italic toggle="yes">COL4A1</italic> pathogenic missense variant that disrupts the collagen triple helix (see <xref ref-type="sec" rid="col4a1-dis.Molecular_Genetics">Molecular Genetics</xref>), a screening test for large duplications/deletions may have a very low yield.</p>
            </list-item>
            <list-item>
              <p><bold>A multi-gene panel</bold> that includes <italic toggle="yes">COL4A1</italic> and other genes of interest (see <xref ref-type="sec" rid="col4a1-dis.Differential_Diagnosis">Differential Diagnosis</xref>) may also be considered. Note: (1) The genes included in the panel and the diagnostic sensitivity of the testing used for each gene vary by laboratory and over time. (2) Some multi-gene panels may include genes not associated with the condition discussed in this <italic toggle="yes">GeneReview</italic>; thus, clinicians need to determine which multi-gene panel provides the best opportunity to identify the genetic cause of condition at the most reasonable cost. (3) Methods used in a panel may include sequence analysis, deletion/duplication analysis, and/or other non-sequencing based tests.</p>
            </list-item>
            <list-item>
              <p><bold>More comprehensive genomic testing</bold> (when available) including whole-exome sequencing (WES) and whole-genome sequencing (WGS) may be considered if single-gene testing (and/or use of a multi-gene panel that includes <italic toggle="yes">COL4A1</italic>) fails to confirm a diagnosis in an individual with features of a <italic toggle="yes">COL4A1</italic>-related disorder. Such testing may provide or suggest a diagnosis not previously considered (e.g., mutation of a different gene or genes that results in a similar clinical presentation). For more information on comprehensive genome sequencing click <related-object link-type="booklink" source-id="gene" document-id="app5" document-type="appendix" object-id="app5.Comprehensive_Genome_Sequencing" object-type="sec">here</related-object>.</p>
            </list-item>
          </list>
          <table-wrap id="col4a1-dis.T.molecular_genetic_testing_u" position="anchor" orientation="portrait">
            <label>Table 1. </label>
            <caption>
              <p>Molecular Genetic Testing Used in <italic toggle="yes">COL4A1</italic>-related disorders</p>
            </caption>
            <table frame="hsides" rules="groups">
              <thead>
                <tr>
                  <th id="hd_h_col4a1-dis.T.molecular_genetic_testing_u_1_1_1_1" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Gene&#x000a0;<sup>1</sup></th>
                  <th id="hd_h_col4a1-dis.T.molecular_genetic_testing_u_1_1_1_2" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Test Method</th>
                  <th id="hd_h_col4a1-dis.T.molecular_genetic_testing_u_1_1_1_3" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Proportion of Probands with a Pathogenic Variant&#x000a0;<sup>2</sup> Detectable by This Method</th>
                </tr>
              </thead>
              <tbody>
                <tr>
                  <td headers="hd_h_col4a1-dis.T.molecular_genetic_testing_u_1_1_1_1" rowspan="2" valign="middle" align="left" scope="row" colspan="1">
                    <italic toggle="yes">COL4A1</italic>
                  </td>
                  <td headers="hd_h_col4a1-dis.T.molecular_genetic_testing_u_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">Sequence analysis&#x000a0;<sup>3</sup></td>
                  <td headers="hd_h_col4a1-dis.T.molecular_genetic_testing_u_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">100%</td>
                </tr>
                <tr>
                  <td headers="hd_h_col4a1-dis.T.molecular_genetic_testing_u_1_1_1_2" valign="middle" colspan="1" align="left" scope="row" rowspan="1">Deletion/duplication analysis&#x000a0;<sup>4</sup></td>
                  <td headers="hd_h_col4a1-dis.T.molecular_genetic_testing_u_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">Unknown&#x000a0;<sup>5</sup></td>
                </tr>
              </tbody>
            </table>
            <table-wrap-foot>
              <fn id="col4a1-dis.TF.1.1">
                <label>1. </label>
                <p>See <related-object source-id="gene" document-id="col4a1-dis" object-id="col4a1-dis.molgen.TA">Table A. Genes and Databases</related-object> for chromosome locus and protein.</p>
              </fn>
              <fn id="col4a1-dis.TF.1.2">
                <label>2. </label>
                <p>See <xref ref-type="sec" rid="col4a1-dis.Molecular_Genetics">Molecular Genetics</xref> for information on allelic variants detected in this gene.</p>
              </fn>
              <fn id="col4a1-dis.TF.1.3">
                <label>3. </label>
                <p>Sequence analysis detects variants that are benign, likely benign, of uncertain significance, likely pathogenic, or pathogenic. Pathogenic variants may include small intragenic deletions/insertions and missense, nonsense, and splice site variants; typically, exon or whole-gene deletions/duplications are not detected. For issues to consider in interpretation of sequence analysis results, click <related-object link-type="booklink" source-id="gene" document-id="app2" document-type="appendix">here</related-object>.</p>
              </fn>
              <fn id="col4a1-dis.TF.1.4">
                <label>4. </label>
                <p>Gene-targeted deletion/duplication analysis detects intragenic deletions or duplications. Methods that may be used can include: quantitative PCR, long-range PCR, multiplex ligation-dependent probe amplification (MLPA), and a gene-targeted microarray designed to detect single-exon deletions or duplications.</p>
              </fn>
              <fn id="col4a1-dis.TF.1.5">
                <label>5. </label>
                <p>No data on detection rate of gene-targeted deletion/duplication analysis are available.</p>
              </fn>
            </table-wrap-foot>
          </table-wrap>
        </sec>
      </sec>
      <sec id="col4a1-dis.Clinical_Characteristics">
        <title>Clinical Characteristics</title>
        <sec id="col4a1-dis.Clinical_Description">
          <title>Clinical Description</title>
          <p><italic toggle="yes">COL4A1</italic>-related disorders cover a spectrum of overlapping phenotypes characterized by a small-vessel brain disease of varying severity including porencephaly, variably associated with eye defects (congenital cataract, retinal arterial tortuosity, eye anterior segment anomaly of Axenfeld-Rieger type) and systemic findings (muscle cramps and/or serum CK elevation, kidney involvement, cerebral aneurysms, Raynaud phenomenon, cardiac arrhythmia, hemolytic anemia).</p>
          <sec id="col4a1-dis.Autosomal_Dominant_Familial_P">
            <title>Autosomal Dominant Familial Porencephaly</title>
            <p>Autosomal dominant familial porencephaly related to <italic toggle="yes">COL4A1</italic> pathogenic variants has been reported in more than 50 individuals [<xref ref-type="bibr" rid="col4a1-dis.REF.gould.2005.1167">Gould et al 2005</xref>, <xref ref-type="bibr" rid="col4a1-dis.REF.breedveld.2006.490">Breedveld et al 2006</xref>, <xref ref-type="bibr" rid="col4a1-dis.REF.van_der_knaap.2006.504">van der Knaap et al 2006</xref>, <xref ref-type="bibr" rid="col4a1-dis.REF.yoneda.2013.48">Yoneda et al 2013</xref>, <xref ref-type="bibr" rid="col4a1-dis.REF.meuwissen.2015.843">Meuwissen et al 2015</xref>]. This condition is characterized by the presence of fluid-filled cavities in the brain, caused by antenatal or perinatal parenchymal hemorrhage and detected by either brain CT, MRI (<xref ref-type="fig" rid="col4a1-dis.F1">Figure 1A</xref>), or fetal ultrasound imaging. In addition to porencephalic cavities, brain imaging shows various degrees of periventricular leukoencephalopathy, microbleeds, lacunar infarct, and calcifications [<xref ref-type="bibr" rid="col4a1-dis.REF.vahedi.2007.1461">Vahedi et al 2007</xref>, <xref ref-type="bibr" rid="col4a1-dis.REF.livingston.2011.227">Livingston et al 2011</xref>, <xref ref-type="bibr" rid="col4a1-dis.REF.ayrignac.2015.284">Ayrignac et al 2015</xref>, <xref ref-type="bibr" rid="col4a1-dis.REF.meuwissen.2015.843">Meuwissen et al 2015</xref>].</p>
            <p>The spectrum of neurologic clinical symptoms varies in degree of severity and age of onset, with wide intrafamilial heterogeneity. Typically, affected individuals may present with infantile hemiparesis, seizures, intellectual disability, dystonia, stroke, and migraine. First manifestations (including intracerebral hemorrhages) may occur in previously asymptomatic adults, and MRI brain anomalies can be clinically silent.</p>
            <p>Congenital cataract is frequently observed in affected individuals. Retinal arteriolar tortuosity is more rarely associated with porencephaly [<xref ref-type="bibr" rid="col4a1-dis.REF.van_der_knaap.2006.504">van der Knaap et al 2006</xref>].</p>
          </sec>
          <sec id="col4a1-dis.Autosomal_Dominant_Brain_Smal">
            <title>Autosomal Dominant Brain Small-Vessel Disease with Hemorrhage</title>
            <p>Autosomal dominant brain small-vessel disease with hemorrhage differs from autosomal dominant familial porencephaly by the absence of porencephalic cavities, while brain imaging demonstrates characteristic brain small-vessel involvement, including diffuse periventricular leukoencephalopathy (<xref ref-type="fig" rid="col4a1-dis.F1">Figure 1B</xref>), lacunar infarcts, microbleeds, dilated perivascular spaces, deep intracerebral hemorrhages, and intracerebral calcifications (<xref ref-type="fig" rid="col4a1-dis.F1">Figure 1C</xref>) [<xref ref-type="bibr" rid="col4a1-dis.REF.vahedi.2007.1461">Vahedi et al 2007</xref>, <xref ref-type="bibr" rid="col4a1-dis.REF.yoneda.2013.48">Yoneda et al 2013</xref>, <xref ref-type="bibr" rid="col4a1-dis.REF.meuwissen.2015.843">Meuwissen et al 2015</xref>].</p>
            <p>Neurologic manifestations are also heterogeneous within families, and vary from infantile hemiparesis with seizure to isolated migraine with aura to absence of clinical symptoms. Single or recurrent intracerebral hemorrhage may occur in non-hypertensive adults who are younger than age 50 years. Such hemorrhages can occur spontaneously, after trauma, or as a result of anticoagulant use; some are fatal. Antenatal intracerebral and intraventricular hemorrhage may be observed using fetal ultrasound examination. Mild cognitive impairment has also been reported in one family [<xref ref-type="bibr" rid="col4a1-dis.REF.sibon.2007.177">Sibon et al 2007</xref>]; however, it is unclear whether this is a separate finding or a manifestation of recurrent stroke.</p>
            <p>Concomitant eye anomalies including retinal arteriolar tortuosity, congenital cataract, and/or anterior segment anomalies of the Axenfeld-Rieger type may be observed [<xref ref-type="bibr" rid="col4a1-dis.REF.sibon.2007.177">Sibon et al 2007</xref>, <xref ref-type="bibr" rid="col4a1-dis.REF.coupry.2010.483">Coupry et al 2010</xref>].</p>
            <p>More rarely, systemic symptoms including serum CK elevation with or without muscle cramps [<xref ref-type="bibr" rid="col4a1-dis.REF.yoneda.2013.48">Yoneda et al 2013</xref>, <xref ref-type="bibr" rid="col4a1-dis.REF.meuwissen.2015.843">Meuwissen et al 2015</xref>] and renal involvement including hematuria, unilateral renal atrophy [<xref ref-type="bibr" rid="col4a1-dis.REF.john.2015.19">John et al 2015</xref>], renal cysts, and hemolytic anemia [<xref ref-type="bibr" rid="col4a1-dis.REF.meuwissen.2015.843">Meuwissen et al 2015</xref>] are observed.</p>
          </sec>
          <sec id="col4a1-dis.HANAC_Syndrome">
            <title>HANAC Syndrome</title>
            <p>HANAC (<italic toggle="yes">h</italic>ereditary <italic toggle="yes">a</italic>ngiopathy with <italic toggle="yes">n</italic>ephropathy, <italic toggle="yes">a</italic>neurysms, and muscle <italic toggle="yes">c</italic>ramps) syndrome has been well characterized in six families [<xref ref-type="bibr" rid="col4a1-dis.REF.plaisier.2007.2687">Plaisier et al 2007</xref>, <xref ref-type="bibr" rid="col4a1-dis.REF.plaisier.2010.2550">Plaisier et al 2010</xref>].</p>
            <p>The small-vessel brain disease of HANAC is usually clinically asymptomatic [<xref ref-type="bibr" rid="col4a1-dis.REF.alamowitch.2009.1873">Alamowitch et al 2009</xref>]. By contrast, the systemic symptoms usually observed in HANAC &#x02013; including muscle cramps, renal involvement, retinal arterial tortuosity, and Raynaud phenomenon &#x02013; are rarely reported in <italic toggle="yes">COL4A1</italic>-related porencephaly or small-vessel brain disease [<xref ref-type="bibr" rid="col4a1-dis.REF.gould.2006.1489">Gould et al 2006</xref>, <xref ref-type="bibr" rid="col4a1-dis.REF.meuwissen.2015.843">Meuwissen et al 2015</xref>].</p>
            <p>
              <bold>Brain involvement</bold>
            </p>
            <list list-type="bullet">
              <list-item>
                <p>Half of affected individuals have: cerebral small-vessel disease characterized by leukoencephalopathy affecting subcortical, periventricular, or pontine regions; dilated perivascular spaces; lacunar infarcts; and microbleeds. None have porencephaly. Only two of the 14 affected individuals have clinical cerebrovascular symptoms: a minor ischemic stroke and a mild post-traumatic intracerebral hemorrhage while on anticoagulants [<xref ref-type="bibr" rid="col4a1-dis.REF.alamowitch.2009.1873">Alamowitch et al 2009</xref>].</p>
              </list-item>
              <list-item>
                <p>Single or multiple intracranial aneurysms, all located on the carotid siphon, have been observed in six individuals, with no rupture episode (<xref ref-type="fig" rid="col4a1-dis.F1">Figure 1D</xref>).</p>
              </list-item>
            </list>
            <p>
              <bold>Renal manifestations</bold>
            </p>
            <list list-type="bullet">
              <list-item>
                <p>One family presented with isolated microscopic hematuria (i.e., without proteinuria or hypertension) and intermittent episodes of gross hematuria. Kidney biopsy was normal by light microscopy, but ultrastructural examination disclosed irregular and abnormal thickening of the basement membranes of the tubules, Bowman&#x02019;s capsule, and interstitial capillaries. Small renal cysts were variably observed.</p>
              </list-item>
              <list-item>
                <p>Three families had renal findings of bilateral cortical and medullary renal cysts without hematuria. Cysts were large, but the overall kidney size was normal (<xref ref-type="fig" rid="col4a1-dis.F2">Figure 2</xref>). Mild renal failure without proteinuria or hypertension may develop in individuals after age 50 years.</p>
              </list-item>
            </list>
            <p><bold>Muscle cramps</bold> involving a variety of muscles usually occur in affected individuals, with first episodes occurring before age three years. Muscle strength was slightly affected in only two individuals. Electromyography does not show a specific abnormality, and muscle biopsy, available in one person only, is normal. All affected individuals have persistent elevation of serum CK concentration.</p>
            <p><bold>Bilateral retinal arteriolar tortuosity</bold> is observed in all individuals with HANAC syndrome (see <bold>Ocular manifestations</bold> below).</p>
            <p><bold>Other manifestations.</bold> Raynaud phenomenon, supraventricular arrhythmia, and liver cyst are variably reported.</p>
          </sec>
          <sec id="col4a1-dis.Additional_Findings_in_COL4A1">
            <title>Additional Findings in <italic toggle="yes">COL4A1</italic>-Related Disorders</title>
            <p><bold>Ocular manifestations</bold> are variably observed in <italic toggle="yes">COL4A1</italic>-related disorders. Three distinct ocular features have been reported:</p>
            <list list-type="bullet">
              <list-item>
                <p><bold>Bilateral retinal arterial tortuosity</bold> is variably present in individuals with small-vessel brain disease with hemorrhage [<xref ref-type="bibr" rid="col4a1-dis.REF.gould.2006.1489">Gould et al 2006</xref>] or with porencephaly [<xref ref-type="bibr" rid="col4a1-dis.REF.van_der_knaap.2006.504">van der Knaap et al 2006</xref>], whereas all individuals with HANAC syndrome exhibited this finding [<xref ref-type="bibr" rid="col4a1-dis.REF.plaisier.2007.2687">Plaisier et al 2007</xref>]. Additionally, one <italic toggle="yes">COL4A1</italic> pathogenic variant has been characterized in individuals with familial retinal arteriolar tortuosity without cerebral or systemic symptoms [<xref ref-type="bibr" rid="col4a1-dis.REF.zenteno.2014.1789">Zenteno et al 2014</xref>]. Fundus examination shows marked tortuosity of second- and third-order retinal arteries, with normal first-order arteries and retinal veins (<xref ref-type="fig" rid="col4a1-dis.F3">Figure 3</xref>). No leakage or staining is observed on fluorescein angiography. Affected individuals experience episodic transient visual loss as a result of retinal hemorrhage occurring spontaneously or after minor stress or trauma. Visual prognosis has been excellent, without retinal sequelae.</p>
              </list-item>
              <list-item>
                <p><bold>Congenital cataract</bold> is reported either as an isolated ocular feature [<xref ref-type="bibr" rid="col4a1-dis.REF.van_der_knaap.2006.504">van der Knaap et al 2006</xref>, <xref ref-type="bibr" rid="col4a1-dis.REF.shah.2010.182">Shah et al 2010</xref>] or associated with other eye anterior segment abnormalities of Axenfeld-Rieger type in families with small-vessel brain disease and porencephaly [<xref ref-type="bibr" rid="col4a1-dis.REF.sibon.2007.177">Sibon et al 2007</xref>, <xref ref-type="bibr" rid="col4a1-dis.REF.coupry.2010.483">Coupry et al 2010</xref>, <xref ref-type="bibr" rid="col4a1-dis.REF.r_dahl.2013.946">R&#x000f8;dahl et al 2013</xref>, <xref ref-type="bibr" rid="col4a1-dis.REF.yoneda.2013.48">Yoneda et al 2013</xref>, <xref ref-type="bibr" rid="col4a1-dis.REF.meuwissen.2015.843">Meuwissen et al 2015</xref>]. Nonsyndromic congenital cataract has also been associated with a <italic toggle="yes">COL4A1</italic> pathogenic variant in a large family [<xref ref-type="bibr" rid="col4a1-dis.REF.xia.2014.97">Xia et al 2014</xref>].</p>
              </list-item>
              <list-item>
                <p><bold>Anterior segment anomaly of Axenfeld-Rieger type</bold> comprises a spectrum of ocular findings affecting the anterior chamber including congenital iris abnormalities, posterior embryotoxon, microcornea, increased intraocular pressure, and glaucoma. It has been described in families presenting with small-vessel brain disease and porencephaly [<xref ref-type="bibr" rid="col4a1-dis.REF.sibon.2007.177">Sibon et al 2007</xref>, <xref ref-type="bibr" rid="col4a1-dis.REF.meuwissen.2015.843">Meuwissen et al 2015</xref>].</p>
              </list-item>
            </list>
            <p>
              <bold>Renal manifestations</bold>
            </p>
            <list list-type="bullet">
              <list-item>
                <p><bold>Bilateral renal cysts</bold> are very frequently observed in individuals with HANAC, and more rarely in affected individuals with small-vessel brain disease. In one family, renal cysts represent the main clinical manifestation, together with hematuria and glomerular filtration rate decrease [<xref ref-type="bibr" rid="col4a1-dis.REF.gale.2016.gfw051">Gale et al 2016</xref>].</p>
              </list-item>
              <list-item>
                <p><bold>Hematuria</bold> has been reported in individuals with porencephaly, small-vessel brain disease, and HANAC [<xref ref-type="bibr" rid="col4a1-dis.REF.meuwissen.2015.843">Meuwissen et al 2015</xref>].</p>
              </list-item>
              <list-item>
                <p><bold>Unilateral renal atrophy</bold> has been reported in two individuals [<xref ref-type="bibr" rid="col4a1-dis.REF.john.2015.19">John et al 2015</xref>].</p>
              </list-item>
              <list-item>
                <p><bold>Glomerular filtration rate decrease</bold> (usually affecting individuals age &#x0003e;40 years) has been observed in individuals with HANAC, as well as in affected individuals from one family presenting with renal cysts and hematuria without brain or extracerebral involvement [<xref ref-type="bibr" rid="col4a1-dis.REF.john.2015.19">John et al 2015</xref>, <xref ref-type="bibr" rid="col4a1-dis.REF.gale.2016.gfw051">Gale et al 2016</xref>].</p>
              </list-item>
            </list>
            <p><bold>Muscle manifestations.</bold> Serum CK elevation and painful muscle cramps, seen in all individuals with HANAC syndrome [<xref ref-type="bibr" rid="col4a1-dis.REF.plaisier.2010.2550">Plaisier et al 2010</xref>], are only variably present in other affected individuals [<xref ref-type="bibr" rid="col4a1-dis.REF.meuwissen.2015.843">Meuwissen et al 2015</xref>]. Muscle biopsy was performed in one affected individual with myopathic defects [<xref ref-type="bibr" rid="col4a1-dis.REF.yoneda.2013.48">Yoneda et al 2013</xref>].</p>
            <p><bold>Cardiac manifestations.</bold> Mitral valve prolapse and supraventricular arrythmia have been characterized in four patients [<xref ref-type="bibr" rid="col4a1-dis.REF.plaisier.2010.2550">Plaisier et al 2010</xref>, <xref ref-type="bibr" rid="col4a1-dis.REF.meuwissen.2015.843">Meuwissen et al 2015</xref>].</p>
            <p><bold>Ultrastructural basement membrane abnormalities</bold> have been demonstrated in skin vessels, at the dermo-epidermal junction, and in kidney.</p>
            <list list-type="bullet">
              <list-item>
                <p>In individuals with HANAC syndrome with hematuria, ultrastructural examination disclosed irregular and abnormal thickening of the basement membranes of the tubules, Bowman&#x02019;s capsule, and interstitial capillaries [<xref ref-type="bibr" rid="col4a1-dis.REF.plaisier.2007.2687">Plaisier et al 2007</xref>]. In the skin, similar alterations including duplication of the basement membrane are seen at the dermo-epidermal junction and in dermal arterioles; vascular smooth muscle cells are dissociated due to abnormal spreading of basement membrane [<xref ref-type="bibr" rid="col4a1-dis.REF.plaisier.2010.2550">Plaisier et al 2010</xref>].</p>
              </list-item>
              <list-item>
                <p>In one individual with autosomal dominant porencephaly, focal disruption and a major increase in thickness of the basement membrane of skin capillaries were found [<xref ref-type="bibr" rid="col4a1-dis.REF.van_der_knaap.2006.504">van der Knaap et al 2006</xref>].</p>
              </list-item>
            </list>
          </sec>
        </sec>
        <sec id="col4a1-dis.GenotypePhenotype_Correlation">
          <title>Genotype-Phenotype Correlations</title>
          <p>The number of <italic toggle="yes">COL4A1</italic> pathogenic variants is too small to explore genotype-phenotype relationships.</p>
          <p>However, all six <italic toggle="yes">COL4A1</italic> pathogenic variants associated with hereditary angiopathy, nephropathy, aneurysms, and muscle cramps (i.e., HANAC syndrome) are localized in exons 24 and 25 [<xref ref-type="bibr" rid="col4a1-dis.REF.plaisier.2007.2687">Plaisier et al 2007</xref>, <xref ref-type="bibr" rid="col4a1-dis.REF.plaisier.2010.2550">Plaisier et al 2010</xref>]. They affect glycine residues localized in a short 30-amino acid region of the protein, whereas all but one pathogenic variant responsible for more severe brain disease, including porencephaly and small-vessel brain disease, are mostly distributed through exons 25 to 51 [<xref ref-type="bibr" rid="col4a1-dis.REF.meuwissen.2015.843">Meuwissen et al 2015</xref>].</p>
        </sec>
        <sec id="col4a1-dis.Penetrance">
          <title>Penetrance</title>
          <p>Penetrance of <italic toggle="yes">COL4A1</italic>-related disorders is probably close to 100%, with expression varying in age of onset and severity of the clinical symptoms, even in the same family; however, these data need verification in larger cohort studies.</p>
        </sec>
        <sec id="col4a1-dis.Prevalence">
          <title>Prevalence</title>
          <p>Prevalence of <italic toggle="yes">COL4A1</italic>-related disorders cannot be established as fewer than 100 families have been described.</p>
          <p>No data on the prevalence of <italic toggle="yes">COL4A1</italic> pathogenic variants in persons with microscopic hematuria or renal cysts are available.</p>
          <p>To date pathogenic variants have been reported in individuals of Dutch, Italian, French, German, American, Chinese, Spanish, and Japanese origin.</p>
        </sec>
      </sec>
      <sec id="col4a1-dis.Genetically_Related_Allelic_D">
        <title>Genetically Related (Allelic) Disorders</title>
        <p>No phenotypes other than those discussed in this <italic toggle="yes">GeneReview</italic> are known to be associated with mutation of <italic toggle="yes">COL4A1.</italic></p>
      </sec>
      <sec id="col4a1-dis.Differential_Diagnosis">
        <title>Differential Diagnosis</title>
        <p><bold><italic toggle="yes">COL4A2-</italic>related porencephaly and intracerebral hemorrhages.</bold> Seven heterozygous <italic toggle="yes">COL4A2</italic> pathogenic variants have been characterized in individuals with either porencephaly (porencephaly type 2; <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://omim.org/entry/614483">OMIM</ext-link>) or intracerebral hemorrhage (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://omim.org/entry/614519">OMIM</ext-link>). Neurologic presentation of individuals with porencephaly type 2 was similar to that observed in <italic toggle="yes">COL4A1-</italic>related porencephaly [<xref ref-type="bibr" rid="col4a1-dis.REF.yoneda.2012.86">Yoneda et al 2012</xref>, <xref ref-type="bibr" rid="col4a1-dis.REF.meuwissen.2015.843">Meuwissen et al 2015</xref>]. Four patients presented with adult-onset intracerebral hemorrhage [<xref ref-type="bibr" rid="col4a1-dis.REF.jeanne.2012.91">Jeanne et al 2012</xref>]. Variably present extracerebral symptoms included cerebellar and optic atrophy, cataracts, intracranial aneurysms, nephropathy, and myopathy [<xref ref-type="bibr" rid="col4a1-dis.REF.verbeek.2012.844">Verbeek et al 2012</xref>, <xref ref-type="bibr" rid="col4a1-dis.REF.gunda.2014.500">Gunda et al 2014</xref>].</p>
        <p><related-object link-type="booklink" source-id="gene" document-id="cadasil" document-type="chapter"><bold>CADASIL</bold></related-object> (<italic toggle="yes">c</italic>erebral <italic toggle="yes">a</italic>utosomal <italic toggle="yes">d</italic>ominant <italic toggle="yes">a</italic>rteriopathy with <italic toggle="yes">s</italic>ubcortical <italic toggle="yes">i</italic>nfarcts and <italic toggle="yes">l</italic>eukoencephalopathy) is characterized by a history of migraine headaches with aura (30%-40% of individuals), mid-adult (30s-60s) onset of cerebrovascular disease, mood disturbance, apathy, cognitive disturbance progressing to dementia, and diffuse white-matter lesions and subcortical infarcts on neuroimaging. The pathologic hallmark of CADASIL is electron-dense granules in the media of arterioles that can often be identified by electron microscopic evaluation of skin biopsies. Mutation of <italic toggle="yes">NOTCH3</italic> causes CADASIL [<xref ref-type="bibr" rid="col4a1-dis.REF.joutel.1996.707">Joutel et al 1996</xref>]. Inherited is autosomal dominant.</p>
        <p><bold>Autosomal dominant retinal vasculopathy with cerebral leukodystrophy (RVCL)</bold> (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://omim.org/entry/192315">OMIM</ext-link>) is a microvascular endotheliopathy, which variably associates a retinal vasculopathy, migraine, Raynaud phenomenon, stroke, and dementia with onset in middle age [<xref ref-type="bibr" rid="col4a1-dis.REF.ophoff.2001.447">Ophoff et al 2001</xref>]. <italic toggle="yes">H</italic>ereditary <italic toggle="yes">e</italic>ndotheliopathy with <italic toggle="yes">r</italic>etinopathy, <italic toggle="yes">n</italic>ephropathy, and <italic toggle="yes">s</italic>troke (HERNS), a distinctive subtype of RVCL, is characterized by brain disease, kidney disease (hematuria and proteinuria), and Raynaud phenomenon. Ultrastructural alterations affecting the glomerular basement membrane and the basement membrane of capillaries in the brain and other tissues have been observed in HERNS [<xref ref-type="bibr" rid="col4a1-dis.REF.jen.1997.1322">Jen et al 1997</xref>]. C terminus pathogenic variants in <italic toggle="yes">TREX1</italic> cause RVCL [<xref ref-type="bibr" rid="col4a1-dis.REF.richards.2007.1068">Richards et al 2007</xref>]. Inheritance is autosomal dominant.</p>
        <p><bold>Porencephalic cysts</bold> may occur after antenatal or neonatal parenchymal hemorrhagic infarction in the context of neonatal alloimmune thrombocytopenia; a coagulopathy like <related-object link-type="booklink" source-id="gene" document-id="von-willebrand" document-type="chapter">von Willebrand disease</related-object>, factor V deficiency (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://omim.org/entry/227400">OMIM</ext-link>), or factor X deficiency (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://omim.org/entry/227600">OMIM</ext-link>); maternal warfarin use; or thrombophilia (most often heterozygosity for factor V Leiden mutation) (see <related-object link-type="booklink" source-id="gene" document-id="factor-v-leiden" document-type="chapter">Factor V Leiden Thrombophilia</related-object>).</p>
        <p><related-object link-type="booklink" source-id="gene" document-id="carasil" document-type="chapter"><bold>CARASIL</bold></related-object> (<italic toggle="yes">c</italic>erebral <italic toggle="yes">a</italic>utosomal <italic toggle="yes">r</italic>ecessive <italic toggle="yes">a</italic>rteriopathy with <italic toggle="yes">s</italic>ubcortical <italic toggle="yes">i</italic>nfarcts and <italic toggle="yes">l</italic>eucoencephalopathy; Maeda-syndrome) is characterized by early-onset changes in the deep white matter of the brain observed on MRI and associated neurologic findings. The most frequent initial symptom is gait disturbance from spasticity beginning between ages 20 and 30 years; 23% of affected individuals have stroke-like episodes before age 40 years. Mood changes (apathy and irritability), pseudobulbar palsy, and cognitive dysfunction begin between ages 20 and 50 years. The disease progresses slowly over the five to 20 years following the onset of neurologic symptoms. This rare disease is caused by pathogenic variants in <italic toggle="yes">HTRA1</italic>; inheritance is autosomal recessive. CARASIL has been reported mostly in Japanese and Chinese families.</p>
        <p><bold>Anophthalmia/microphthalmia (A/M).</bold> Microphthalmia refers to a globe with a total axial length that is at least two standard deviations below the mean for age. Anophthalmia refers to complete absence of the globe in the presence of ocular adnexa (eyelids, conjunctiva, and lacrimal apparatus). A/M is a genetically heterogenous disorder that has been associated with pathogenic variants in more than 70 genes. <italic toggle="yes">SOX2</italic>, <italic toggle="yes">OTX2</italic>, and <italic toggle="yes">FOXE3</italic> are among the genes most commonly associated with A/M [<xref ref-type="bibr" rid="col4a1-dis.REF.chassaing.2014.326">Chassaing et al 2014</xref>] (see <related-object link-type="booklink" source-id="gene" document-id="anophthalmia-ov" document-type="chapter">Microphthalmia/Anophthalmia/Coloboma Spectrum</related-object>).</p>
      </sec>
      <sec id="col4a1-dis.Management">
        <title>Management</title>
        <sec id="col4a1-dis.Evaluations_Following_Initial">
          <title>Evaluations Following Initial Diagnosis</title>
          <p>To establish the extent of disease and needs in an individual diagnosed with <italic toggle="yes">COL4A1</italic>-related disorders, the following are recommended:</p>
          <list list-type="bullet">
            <list-item>
              <p>Brain MRI including T<sub>1</sub>-weighted saggital, T<sub>2</sub>-weighted axial, and FLAIR axial images</p>
            </list-item>
            <list-item>
              <p>Brain angiographic CT scan</p>
            </list-item>
            <list-item>
              <p>Ophthalmologic examination including fundoscopic examination and slit-lamp examination</p>
            </list-item>
            <list-item>
              <p>Kidney and liver ultrasound examination or CT</p>
            </list-item>
            <list-item>
              <p>Measurement of serum CK concentration</p>
            </list-item>
            <list-item>
              <p>Measurement of serum creatinine concentration and estimation of the glomerular filtration rate</p>
            </list-item>
            <list-item>
              <p>Evaluation for the presence of hematuria</p>
            </list-item>
            <list-item>
              <p>Electrocardiogram (ECG); echocardiography and ambulatory ECG monitoring in individuals presenting with palpitations</p>
            </list-item>
            <list-item>
              <p>Consultation with a clinical geneticist and/or genetic counselor</p>
            </list-item>
          </list>
        </sec>
        <sec id="col4a1-dis.Treatment_of_Manifestations">
          <title>Treatment of Manifestations</title>
          <p>Hypertensive individuals must be treated to reduce the global risk of stroke.</p>
          <p>Supportive care including practical help, emotional support, and counseling are appropriate for affected individuals and their families.</p>
          <p>No specific support exists for individuals with <italic toggle="yes">COL4A1</italic>-related disorders.</p>
          <list list-type="bullet">
            <list-item>
              <p>Seizures are managed using standard protocols.</p>
            </list-item>
            <list-item>
              <p>Cataract surgery may be required for individuals with severe lens opacities.</p>
            </list-item>
            <list-item>
              <p>Glaucoma is initially treated with topical anti-glaucoma medication. Surgery is reserved for eyes that do not respond to medical therapy.</p>
            </list-item>
            <list-item>
              <p>Symptomatic paroxysmal supraventricular arrhythmia should be treated with antiarrhythmic drugs (beta blockers).</p>
            </list-item>
            <list-item>
              <p>Surgical or endovascular treatment should be discussed for asymptomatic intracranial aneurysms &#x0003e;10.0 mm in diameter.</p>
            </list-item>
          </list>
        </sec>
        <sec id="col4a1-dis.Prevention_of_Primary_Manifes">
          <title>Prevention of Primary Manifestations</title>
          <p>Avoidance of anticoagulant exposure and activities that involve an increased risk for head trauma may decrease the risk for intracerebral hemorrhage.</p>
        </sec>
        <sec id="col4a1-dis.Prevention_of_Secondary_Compl">
          <title>Prevention of Secondary Complications</title>
          <p>See <xref ref-type="sec" rid="col4a1-dis.Prevention_of_Primary_Manifes">Prevention of Primary Manifestations</xref>.</p>
        </sec>
        <sec id="col4a1-dis.Surveillance">
          <title>Surveillance</title>
          <p>The interval at which individuals with <italic toggle="yes">COL4A1</italic>-related disorders should be seen for follow up depends on the severity and type of symptoms.</p>
          <p>Annual clinical evaluation is reasonable.</p>
          <p>Regular brain imaging can be proposed, especially to evaluate the size of asymptomatic cerebral aneurysms.</p>
        </sec>
        <sec id="col4a1-dis.AgentsCircumstances_to_Avoid">
          <title>Agents/Circumstances to Avoid</title>
          <p>The following should be avoided:</p>
          <list list-type="bullet">
            <list-item>
              <p>Smoking because it increases the global risk of stroke</p>
            </list-item>
            <list-item>
              <p>Hypertension because it increases the risk of stroke</p>
            </list-item>
            <list-item>
              <p>Sustained head pressure during birth or postnatal physical activities that may cause head trauma [<xref ref-type="bibr" rid="col4a1-dis.REF.gould.2006.1489">Gould et al 2006</xref>]</p>
            </list-item>
            <list-item>
              <p>Anticoagulant use [<xref ref-type="bibr" rid="col4a1-dis.REF.gould.2006.1489">Gould et al 2006</xref>]</p>
            </list-item>
          </list>
        </sec>
        <sec id="col4a1-dis.Evaluation_of_Relatives_at_Ri">
          <title>Evaluation of Relatives at Risk</title>
          <p>See <xref ref-type="sec" rid="col4a1-dis.Related_Genetic_Counseling_Is">Genetic Counseling</xref> for issues related to testing of at-risk relatives for genetic counseling purposes.</p>
        </sec>
        <sec id="col4a1-dis.Pregnancy_Management">
          <title>Pregnancy Management</title>
          <p>Cesarean delivery for pregnancies in which the fetus is at risk for a <italic toggle="yes">COL4A1</italic>-related disorder is recommended to prevent brain vascular injury attributable to birth trauma in newborns [<xref ref-type="bibr" rid="col4a1-dis.REF.gould.2006.1489">Gould et al 2006</xref>].</p>
        </sec>
        <sec id="col4a1-dis.Therapies_Under_Investigation">
          <title>Therapies Under Investigation</title>
          <p>Search <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://clinicaltrials.gov/">ClinicalTrials.gov</ext-link> for access to information on clinical studies for a wide range of diseases and conditions. Note: There may not be clinical trials for this disorder.</p>
        </sec>
      </sec>
      <sec id="col4a1-dis.Genetic_Counseling">
        <title>Genetic Counseling</title>
        <sec id="col4a1-dis.Mode_of_Inheritance">
          <title>Mode of Inheritance</title>
          <p><italic toggle="yes">COL4A1</italic>-related disorders are inherited in an autosomal dominant manner.</p>
        </sec>
        <sec id="col4a1-dis.Risk_to_Family_Members">
          <title>Risk to Family Members</title>
          <p>
            <bold>Parents of a proband</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p>At least 50% of individuals diagnosed with a <italic toggle="yes">COL4A1</italic>-related disorder have an affected parent [<xref ref-type="bibr" rid="col4a1-dis.REF.meuwissen.2015.843">Meuwissen et al 2015</xref>].</p>
            </list-item>
            <list-item>
              <p>A proband with a <italic toggle="yes">COL4A1</italic>-related disorder may have the disorder as the result of a <italic toggle="yes">de novo</italic> pathogenic variant. The proportion of cases caused by <italic toggle="yes">de novo</italic> pathogenic variants is estimated to be at least 27% [<xref ref-type="bibr" rid="col4a1-dis.REF.meuwissen.2015.843">Meuwissen et al 2015</xref>].</p>
            </list-item>
            <list-item>
              <p>Recommendations for the evaluation of parents of a proband with an apparent <italic toggle="yes">de novo</italic> pathogenic variant include molecular genetic testing for the pathogenic variant identified in the proband, medical record review, brain imaging by MRI, and ophthalmologic evaluation.</p>
            </list-item>
            <list-item>
              <p>If the <italic toggle="yes">COL4A1</italic> pathogenic variant found in the proband cannot be detected in leukocyte DNA of either parent, possible explanations include a <italic toggle="yes">de novo</italic> pathogenic variant in the proband or germline mosaicism in a parent. Though theoretically possible, no instances of germline mosaicism have been reported.</p>
            </list-item>
            <list-item>
              <p>The family history of some individuals diagnosed with a <italic toggle="yes">COL4A1</italic>-related disorder may appear to be negative because of failure to recognize the disorder in family members, early death of the parent before the onset of symptoms, or late onset of the disease in the affected parent. Therefore, an apparently negative family history cannot be confirmed unless appropriate evaluations and molecular genetic testing have been performed on the parents of the proband.</p>
            </list-item>
          </list>
          <p>
            <bold>Sibs of a proband</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p>The risk to the sibs of the proband depends on the genetic status of the proband&#x02019;s parents: if a parent of the proband is affected, the risk to the sibs is 50%.</p>
            </list-item>
            <list-item>
              <p>Although penetrance of <italic toggle="yes">COL4A1</italic>-related disorders is probably close to 100%, age of onset and severity of the clinical symptoms vary, even in the same family.</p>
            </list-item>
            <list-item>
              <p>The sibs of a proband with clinically unaffected parents are still at increased risk (for the disorder) because of the possibility of reduced penetrance in a parent.</p>
            </list-item>
            <list-item>
              <p>If the <italic toggle="yes">COL4A1</italic> pathogenic variant found in the proband cannot be detected in the leukocyte DNA of either parent, the risk to sibs is slightly greater than that of the general population (though still &#x0003c;1%) because of the theoretic possibility of parental germline mosaicism.</p>
            </list-item>
          </list>
          <p><bold>Offspring of a proband.</bold> Each child of an individual with a <italic toggle="yes">COL4A1</italic>-related disorder has a 50% chance of inheriting the <italic toggle="yes">COL4A1</italic> pathogenic variant.</p>
          <p><bold>Other family members.</bold> The risk to other family members depends on the status of the proband's parents: if a parent has the <italic toggle="yes">COL4A1</italic> pathogenic variant, his or her family members may be at risk.</p>
        </sec>
        <sec id="col4a1-dis.Related_Genetic_Counseling_Is">
          <title>Related Genetic Counseling Issues</title>
          <p><bold>Considerations in families with an apparent <italic toggle="yes">de novo</italic> pathogenic variant.</bold> When neither parent of a proband with an autosomal dominant condition has the pathogenic variant identified in the proband or clinical evidence of the disorder, the pathogenic variant is likely <italic toggle="yes">de novo</italic>. However, non-medical explanations including alternate paternity or maternity (e.g., with assisted reproduction) and undisclosed adoption could also be explored.</p>
          <p>
            <bold>Family planning</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p>The optimal time for determination of genetic risk and discussion of the availability of prenatal testing is before pregnancy.</p>
            </list-item>
            <list-item>
              <p>It is appropriate to offer genetic counseling (including discussion of potential risks to offspring and reproductive options) to young adults who are affected or at risk.</p>
            </list-item>
          </list>
          <p><bold>DNA banking</bold> is the storage of DNA (typically extracted from white blood cells) for possible future use. Because it is likely that testing methodology and our understanding of genes, allelic variants, and diseases will improve in the future, consideration should be given to banking DNA of affected individuals.</p>
        </sec>
        <sec id="col4a1-dis.Prenatal_Testing_and_Preimpla">
          <title>Prenatal Testing and Preimplantation Genetic Diagnosis</title>
          <p>Once the <italic toggle="yes">COL4A1</italic> pathogenic variant has been identified in an affected family member, prenatal testing and preimplantation genetic diagnosis for a pregnancy at increased risk for a <italic toggle="yes">COL4A1</italic>-related disorder are possible options.</p>
          <p>Differences in perspective may exist among medical professionals and within families regarding the use of prenatal testing, particularly if the testing is being considered for the purpose of pregnancy termination rather than early diagnosis. Although most centers would consider decisions regarding prenatal testing to be the choice of the parents, discussion of these issues is appropriate.</p>
        </sec>
      </sec>
      <sec id="col4a1-dis.Resources">
        <title>Resources</title>
      </sec>
      <sec id="col4a1-dis.Molecular_Genetics">
        <title>Molecular Genetics</title>
        <p><bold>Gene structure.</bold>
<italic toggle="yes">COL4A1</italic> consists of 52 exons spanning roughly 158 kb. For a detailed summary of gene and protein information, see <related-object source-id="gene" document-id="col4a1-dis" object-id="col4a1-dis.molgen.TA">Table A</related-object>, <bold>Gene</bold>.</p>
        <p><bold>Pathogenic allelic variants.</bold> Most of the sequence alterations in <italic toggle="yes">COL4A1</italic> are missense variants (leading to the substitution of a glycine residue in the collagenous domain of the protein) located between exons 24 and 49. One pathogenic variant affects the start codon. One small duplication is located within the non-collagenous domain (NC-1) located at the C-terminal end of the protein.</p>
        <table-wrap id="col4a1-dis.T.selected_col4a1_pathogenic" position="anchor" orientation="portrait">
          <label>Table 2. </label>
          <caption>
            <p>Selected <italic toggle="yes">COL4A1</italic> Pathogenic Variants</p>
          </caption>
          <table frame="hsides" rules="groups">
            <thead>
              <tr>
                <th id="hd_h_col4a1-dis.T.selected_col4a1_pathogenic_1_1_1_1" valign="middle" align="left" scope="col" rowspan="1" colspan="1">DNA Nucleotide Change</th>
                <th id="hd_h_col4a1-dis.T.selected_col4a1_pathogenic_1_1_1_2" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Predicted Protein Change</th>
                <th id="hd_h_col4a1-dis.T.selected_col4a1_pathogenic_1_1_1_3" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Reference Sequences</th>
              </tr>
            </thead>
            <tbody>
              <tr>
                <td headers="hd_h_col4a1-dis.T.selected_col4a1_pathogenic_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">c.1A&#x0003e;T</td>
                <td headers="hd_h_col4a1-dis.T.selected_col4a1_pathogenic_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">p.Met1Leu</td>
                <td headers="hd_h_col4a1-dis.T.selected_col4a1_pathogenic_1_1_1_3" rowspan="19" valign="middle" align="left" colspan="1">
                  <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/entrez/viewer.fcgi?val=NM_001845.4">NM_001845.4</ext-link>
                  <break/>
                  <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/entrez/viewer.fcgi?val=NP_001836.2">NP_001836.2</ext-link>
                </td>
              </tr>
              <tr>
                <td headers="hd_h_col4a1-dis.T.selected_col4a1_pathogenic_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">c.1493G&#x0003e;T</td>
                <td headers="hd_h_col4a1-dis.T.selected_col4a1_pathogenic_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">p.Gly498Val</td>
              </tr>
              <tr>
                <td headers="hd_h_col4a1-dis.T.selected_col4a1_pathogenic_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">c.1528G&#x0003e;A</td>
                <td headers="hd_h_col4a1-dis.T.selected_col4a1_pathogenic_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">p.Gly510Arg</td>
              </tr>
              <tr>
                <td headers="hd_h_col4a1-dis.T.selected_col4a1_pathogenic_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">c.1555G&#x0003e;A</td>
                <td headers="hd_h_col4a1-dis.T.selected_col4a1_pathogenic_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">p.Gly519Arg</td>
              </tr>
              <tr>
                <td headers="hd_h_col4a1-dis.T.selected_col4a1_pathogenic_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">c.1583G&#x0003e;A</td>
                <td headers="hd_h_col4a1-dis.T.selected_col4a1_pathogenic_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">p.Gly528Glu</td>
              </tr>
              <tr>
                <td headers="hd_h_col4a1-dis.T.selected_col4a1_pathogenic_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">c.1769G&#x0003e;A</td>
                <td headers="hd_h_col4a1-dis.T.selected_col4a1_pathogenic_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">p.Gly562Glu</td>
              </tr>
              <tr>
                <td headers="hd_h_col4a1-dis.T.selected_col4a1_pathogenic_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">c.2122G&#x0003e;A</td>
                <td headers="hd_h_col4a1-dis.T.selected_col4a1_pathogenic_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">p.Gly708Arg</td>
              </tr>
              <tr>
                <td headers="hd_h_col4a1-dis.T.selected_col4a1_pathogenic_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">c.2159G&#x0003e;A</td>
                <td headers="hd_h_col4a1-dis.T.selected_col4a1_pathogenic_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">p.Gly720Asp</td>
              </tr>
              <tr>
                <td headers="hd_h_col4a1-dis.T.selected_col4a1_pathogenic_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">c.2245G&#x0003e;A</td>
                <td headers="hd_h_col4a1-dis.T.selected_col4a1_pathogenic_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">p.Gly749Ser</td>
              </tr>
              <tr>
                <td headers="hd_h_col4a1-dis.T.selected_col4a1_pathogenic_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">c.2317G&#x0003e;A</td>
                <td headers="hd_h_col4a1-dis.T.selected_col4a1_pathogenic_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">p.Gly773</td>
              </tr>
              <tr>
                <td headers="hd_h_col4a1-dis.T.selected_col4a1_pathogenic_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">c.2345G&#x0003e;C</td>
                <td headers="hd_h_col4a1-dis.T.selected_col4a1_pathogenic_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">p.Gly782Ala</td>
              </tr>
              <tr>
                <td headers="hd_h_col4a1-dis.T.selected_col4a1_pathogenic_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">c.2413G&#x0003e;A</td>
                <td headers="hd_h_col4a1-dis.T.selected_col4a1_pathogenic_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">p.Gly805Arg</td>
              </tr>
              <tr>
                <td headers="hd_h_col4a1-dis.T.selected_col4a1_pathogenic_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">c.3389G&#x0003e;A</td>
                <td headers="hd_h_col4a1-dis.T.selected_col4a1_pathogenic_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">p.Gly1130Asp</td>
              </tr>
              <tr>
                <td headers="hd_h_col4a1-dis.T.selected_col4a1_pathogenic_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">c.3706G&#x0003e;A</td>
                <td headers="hd_h_col4a1-dis.T.selected_col4a1_pathogenic_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">p.Gly1236Arg</td>
              </tr>
              <tr>
                <td headers="hd_h_col4a1-dis.T.selected_col4a1_pathogenic_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">c.3976G&#x0003e;A</td>
                <td headers="hd_h_col4a1-dis.T.selected_col4a1_pathogenic_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">p.Gly1326Arg</td>
              </tr>
              <tr>
                <td headers="hd_h_col4a1-dis.T.selected_col4a1_pathogenic_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">c.4267G&#x0003e;C</td>
                <td headers="hd_h_col4a1-dis.T.selected_col4a1_pathogenic_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">p.Gly1423Arg</td>
              </tr>
              <tr>
                <td headers="hd_h_col4a1-dis.T.selected_col4a1_pathogenic_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">c.4582-4586dupCCCAT</td>
                <td headers="hd_h_col4a1-dis.T.selected_col4a1_pathogenic_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">p.Met1529IlefsTer15</td>
              </tr>
              <tr>
                <td headers="hd_h_col4a1-dis.T.selected_col4a1_pathogenic_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">c.4611_4612insG</td>
                <td headers="hd_h_col4a1-dis.T.selected_col4a1_pathogenic_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">p.Thr1537fs</td>
              </tr>
              <tr>
                <td headers="hd_h_col4a1-dis.T.selected_col4a1_pathogenic_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">c.4738G&#x0003e;C</td>
                <td headers="hd_h_col4a1-dis.T.selected_col4a1_pathogenic_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">p.Gly1580Arg</td>
              </tr>
            </tbody>
          </table>
          <table-wrap-foot>
            <fn>
              <p>Note on variant classification: Variants listed in the table have been provided by the authors. <italic toggle="yes">GeneReviews</italic> staff have not independently verified the classification of variants.</p>
            </fn>
            <fn>
              <p>Note on nomenclature: <italic toggle="yes">GeneReviews</italic> follows the standard naming conventions of the Human Genome Variation Society (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://varnomen.hgvs.org/">varnomen.hgvs.org</ext-link>). See <related-object link-type="booklink" source-id="gene" document-id="app3" document-type="appendix">Quick Reference</related-object> for an explanation of nomenclature.</p>
            </fn>
          </table-wrap-foot>
        </table-wrap>
        <p><bold>Normal gene product.</bold>
<italic toggle="yes">COL4A1</italic> encodes the alpha 1 chain of type IV collagen. Type IV collagen is the main component of basement membranes. The six different type IV collagen alpha chains described all consist of a small amino-terminal 7S domain, a large collagenous domain containing the classic Gly-X-Y repeat, and a carboxy-terminal non-collagenous NC1 domain. Specific interactions between NC1 domains initiate the formation of only three different trimers: &#x003b1;1&#x003b1;1&#x003b1;2, &#x003b1;3&#x003b1;4&#x003b1;5, and &#x003b1;5&#x003b1;5&#x003b1;6. Glycine residues play an important role for the stabilization of collagenous triple helical domain. Isoforms of type IV collagen display a tissue- and developmental-specific distribution that explains the heterogeneity of basement membrane composition. The &#x003b1;1&#x003b1;1&#x003b1;2 (IV) trimer is widely expressed, whereas the &#x003b1;3&#x003b1;4&#x003b1;5 (IV) and &#x003b1;5&#x003b1;5&#x003b1;6 (IV) trimers display a more tissue-restricted expression.</p>
        <p><bold>Abnormal gene product.</bold> Most of the pathogenic variants reported in <italic toggle="yes">COL4A1</italic>-related disorders affect highly conserved glycine residues within the collagenous domain of the protein. These amino-acid changes are predicted to result in detrimental effect on collagen &#x003b1;1&#x003b1;1&#x003b1;2 (IV) triple helix formation and stability. Six pathogenic variants are localized in the non-collagenous (NC1) domain that contains recognition sequences involved in the collagen &#x003b1;1&#x003b1;1&#x003b1;2 (IV) triple helix assembly. One pathogenic variant (p.Met1Leu) affects the start codon, resulting in an unknown effect on protein synthesis (see <xref ref-type="table" rid="col4a1-dis.T.selected_col4a1_pathogenic">Table 2</xref>). Two pathogenic variants affect splice sites, leading to exon deletions as demonstrated by cDNA analysis.</p>
      </sec>
      <sec id="col4a1-dis.References">
        <title>References</title>
        <sec id="col4a1-dis.Literature_Cited">
          <title>Literature Cited</title>
          <ref-list id="col4a1-dis.Literature_Cited.reflist0">
            <ref id="col4a1-dis.REF.alamowitch.2009.1873">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Alamowitch</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Plaisier</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Favrole</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Prost</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chen</surname>
                    <given-names>Z</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Van Agtmael</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Marro</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ronco</surname>
                    <given-names>P</given-names>
                  </name>
                </person-group>
                <year>2009</year>
                <article-title>Cerebrovascular disease related to COL4A1 mutations in HANAC syndrome.</article-title>
                <source>Neurology</source>
                <volume>73</volume>
                <fpage>1873</fpage>
                <lpage>82</lpage>
                <pub-id pub-id-type="pmid">19949034</pub-id>
              </element-citation>
            </ref>
            <ref id="col4a1-dis.REF.ayrignac.2015.284">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Ayrignac</surname>
                    <given-names>X</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Carra-Dalliere</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Menjot de Champfleur</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Denier</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Aubourg</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bellesme</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Castelnovo</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pelletier</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Audoin</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kaphan</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>de Seze</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Collongues</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Blanc</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chanson</surname>
                    <given-names>JB</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Magnin</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Berger</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vukusic</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Durand-Dubief</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Camdessanche</surname>
                    <given-names>JP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cohen</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lebrun-Frenay</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Brassat</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Clanet</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vermersch</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zephir</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Outteryck</surname>
                    <given-names>O</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wiertlewski</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Laplaud</surname>
                    <given-names>DA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ouallet</surname>
                    <given-names>JC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Brochet</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Goizet</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Debouverie</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pittion</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Edan</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Deburghgraeve</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Le Page</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Verny</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Amati-Bonneau</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bonneau</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hannequin</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Guyant-Mar&#x000e9;chal</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Derache</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Defer</surname>
                    <given-names>GL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Moreau</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Giroud</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Guennoc</surname>
                    <given-names>AM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Clavelou</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Taithe</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mathis</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Neau</surname>
                    <given-names>JP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Magy</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Devoize</surname>
                    <given-names>JL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bataillard</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Masliah-Planchon</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dorboz</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tournier-Lasserve</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Levade</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Boespflug Tanguy</surname>
                    <given-names>O</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Labauge</surname>
                    <given-names>P</given-names>
                  </name>
                </person-group>
                <year>2015</year>
                <article-title>Adult-onset genetic leukoencephalopathies: A MRI pattern-based approach in a comprehensive study of 154 patients.</article-title>
                <source>Brain</source>
                <volume>138</volume>
                <fpage>284</fpage>
                <lpage>92</lpage>
                <pub-id pub-id-type="pmid">25527826</pub-id>
              </element-citation>
            </ref>
            <ref id="col4a1-dis.REF.breedveld.2006.490">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Breedveld</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>de Coo</surname>
                    <given-names>RF</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lequin</surname>
                    <given-names>MH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Arts</surname>
                    <given-names>WFM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Heuting</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gould</surname>
                    <given-names>DB</given-names>
                  </name>
                  <name name-style="western">
                    <surname>John</surname>
                    <given-names>SWM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Oostra</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mancini</surname>
                    <given-names>GMS</given-names>
                  </name>
                </person-group>
                <year>2006</year>
                <article-title>Novel mutations in three families confirm a major role of COL4A1 in hereditary porencephaly.</article-title>
                <source>J Med Genet</source>
                <volume>43</volume>
                <fpage>490</fpage>
                <lpage>5</lpage>
                <pub-id pub-id-type="pmid">16107487</pub-id>
              </element-citation>
            </ref>
            <ref id="col4a1-dis.REF.chassaing.2014.326">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Chassaing</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Causse</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vigouroux</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Delahaye</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Alessandri</surname>
                    <given-names>JL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Boespflug-Tanguy</surname>
                    <given-names>O</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Boute-Benejean</surname>
                    <given-names>O</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dollfus</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Duban-Bedu</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gilbert-Dussardier</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Giuliano</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gonzales</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Holder-Espinasse</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Isidor</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jacquemont</surname>
                    <given-names>ML</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lacombe</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Martin-Coignard</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mathieu-Dramard</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Odent</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Picone</surname>
                    <given-names>O</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pinson</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Quelin</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sigaudy</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Toutain</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Thauvin-Robinet</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kaplan</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Calvas</surname>
                    <given-names>P</given-names>
                  </name>
                </person-group>
                <year>2014</year>
                <article-title>Molecular findings and clinical data in a cohort of 150 patients with anophthalmia/microphthalmia.</article-title>
                <source>Clin Genet</source>
                <volume>86</volume>
                <fpage>326</fpage>
                <lpage>34</lpage>
                <pub-id pub-id-type="pmid">24033328</pub-id>
              </element-citation>
            </ref>
            <ref id="col4a1-dis.REF.coupry.2010.483">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Coupry</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sibon</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mortemousque</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rouanet</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mine</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Goizet</surname>
                    <given-names>C</given-names>
                  </name>
                </person-group>
                <article-title>Ophthalmological features associated with COL4A1 mutations.</article-title>
                <source>Arch Ophthalmol.</source>
                <year>2010</year>
                <volume>128</volume>
                <fpage>483</fpage>
                <lpage>9</lpage>
                <pub-id pub-id-type="pmid">20385946</pub-id>
              </element-citation>
            </ref>
            <ref id="col4a1-dis.REF.gale.2016.gfw051">
              <mixed-citation publication-type="journal"><person-group><name name-style="western"><surname>Gale</surname><given-names>DP</given-names></name><name name-style="western"><surname>Oygar</surname><given-names>DD</given-names></name><name name-style="western"><surname>Lin</surname><given-names>F</given-names></name><name name-style="western"><surname>Oygar</surname><given-names>PD</given-names></name><name name-style="western"><surname>Khan</surname><given-names>N</given-names></name><name name-style="western"><surname>Connor</surname><given-names>TM</given-names></name><name name-style="western"><surname>Lapsley</surname><given-names>M</given-names></name><name name-style="western"><surname>Maxwell</surname><given-names>PH</given-names></name><name name-style="western"><surname>Neild</surname><given-names>GH</given-names></name></person-group><article-title>A novel COL4A1 frameshift mutation in familial kidney disease: the importance of the C-terminal NC1 domain of type IV collagen.</article-title><source>Nephrol Dial Transplant.</source><year>2016</year><month>Apr</month><day>8</day>pii<fpage>gfw051</fpage><comment>Epub ahead of print</comment><pub-id pub-id-type="pmid">27190376</pub-id></mixed-citation>
            </ref>
            <ref id="col4a1-dis.REF.gould.2005.1167">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Gould</surname>
                    <given-names>DB</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Phalan</surname>
                    <given-names>FC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Breedveld</surname>
                    <given-names>GJ</given-names>
                  </name>
                </person-group>
                <year>2005</year>
                <article-title>Mutations in Col4a1 cause perinatal cerebral hemorrhage and porencephaly.</article-title>
                <source>Science</source>
                <volume>308</volume>
                <fpage>1167</fpage>
                <lpage>71</lpage>
                <pub-id pub-id-type="pmid">15905400</pub-id>
              </element-citation>
            </ref>
            <ref id="col4a1-dis.REF.gould.2006.1489">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Gould</surname>
                    <given-names>DB</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Phalan</surname>
                    <given-names>FC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>van Mil</surname>
                    <given-names>SE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sundberg</surname>
                    <given-names>JP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vahedi</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Massin</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bousser</surname>
                    <given-names>MG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Heuting</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Miner</surname>
                    <given-names>JH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tournier-Lasserve</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>John</surname>
                    <given-names>SWM</given-names>
                  </name>
                </person-group>
                <year>2006</year>
                <article-title>Role of COL4A1 in small-vessel disease and hemorrhagic stroke.</article-title>
                <source>N Engl J Med</source>
                <volume>354</volume>
                <fpage>1489</fpage>
                <lpage>96</lpage>
                <pub-id pub-id-type="pmid">16598045</pub-id>
              </element-citation>
            </ref>
            <ref id="col4a1-dis.REF.gunda.2014.500">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Gunda</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mine</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kov&#x000e1;cs</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Horny&#x000e1;k</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bereczki</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>V&#x000e1;rallyay</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rudas</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Audrezet</surname>
                    <given-names>MP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tournier-Lasserve</surname>
                    <given-names>E</given-names>
                  </name>
                </person-group>
                <article-title>COL4A2 mutation causing adult onset recurrent intracerebral hemorrhage and leukoencephalopathy.</article-title>
                <source>J Neurol.</source>
                <year>2014</year>
                <volume>261</volume>
                <fpage>500</fpage>
                <lpage>3</lpage>
                <pub-id pub-id-type="pmid">24390199</pub-id>
              </element-citation>
            </ref>
            <ref id="col4a1-dis.REF.jeanne.2012.91">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Jeanne</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Labelle-Dumais</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jorgensen</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kauffman</surname>
                    <given-names>WB</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mancini</surname>
                    <given-names>GM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Favor</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Valant</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Greenberg</surname>
                    <given-names>SM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rosand</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gould</surname>
                    <given-names>DB</given-names>
                  </name>
                </person-group>
                <year>2012</year>
                <article-title>COL4A2 mutations impair COL4A1 and COL4A2 secretion and cause hemorrhagic stroke.</article-title>
                <source>Am J Hum Genet</source>
                <volume>90</volume>
                <fpage>91</fpage>
                <lpage>101</lpage>
                <pub-id pub-id-type="pmid">22209247</pub-id>
              </element-citation>
            </ref>
            <ref id="col4a1-dis.REF.jen.1997.1322">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Jen</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cohen</surname>
                    <given-names>AH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Yue</surname>
                    <given-names>Q</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Stout</surname>
                    <given-names>JT</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vinters</surname>
                    <given-names>HV</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nelson</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Baloh</surname>
                    <given-names>RW</given-names>
                  </name>
                </person-group>
                <year>1997</year>
                <article-title>Hereditary endotheliopathy with retinopathy, nephropathy, and stroke</article-title>
                <source>Neurology</source>
                <volume>49</volume>
                <fpage>1322</fpage>
                <lpage>30</lpage>
                <pub-id pub-id-type="pmid">9371916</pub-id>
              </element-citation>
            </ref>
            <ref id="col4a1-dis.REF.john.2015.19">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>John</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jehi</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Manno</surname>
                    <given-names>EM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Conway</surname>
                    <given-names>DS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Uchino</surname>
                    <given-names>K</given-names>
                  </name>
                </person-group>
                <year>2015</year>
                <article-title>COL4A1 gene mutation--beyond a vascular syndrome.</article-title>
                <source>Seizure</source>
                <volume>31</volume>
                <fpage>19</fpage>
                <lpage>21</lpage>
                <pub-id pub-id-type="pmid">26362372</pub-id>
              </element-citation>
            </ref>
            <ref id="col4a1-dis.REF.joutel.1996.707">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Joutel</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Corpechot</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ducros</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vahedi</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chabriat</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mouton</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Alamowitch</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Domenga</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>C&#x000e9;cillion</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Marechal</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Maciazek</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vayssiere</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cruaud</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cabanis</surname>
                    <given-names>EA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ruchoux</surname>
                    <given-names>MM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Weissenbach</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bach</surname>
                    <given-names>JF</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bousser</surname>
                    <given-names>MG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tournier-Lasserve</surname>
                    <given-names>E</given-names>
                  </name>
                </person-group>
                <year>1996</year>
                <article-title>Notch3 mutations in CADASIL, a hereditary adult-onset condition causing stroke and dementia.</article-title>
                <source>Nature</source>
                <volume>383</volume>
                <fpage>707</fpage>
                <lpage>10</lpage>
                <pub-id pub-id-type="pmid">8878478</pub-id>
              </element-citation>
            </ref>
            <ref id="col4a1-dis.REF.livingston.2011.227">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Livingston</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Doherty</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Orcesi</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tonduti</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Piechiecchio</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>La Piana</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tournier-Lasserve</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Majumdar</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tomkins</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rice</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kneen</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>van der Knaap</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Crow</surname>
                    <given-names>Y</given-names>
                  </name>
                </person-group>
                <year>2011</year>
                <article-title>COL4A1 mutations associated with a characteristic pattern of intracranial calcification.</article-title>
                <source>Neuropediatrics.</source>
                <volume>42</volume>
                <fpage>227</fpage>
                <lpage>33</lpage>
                <pub-id pub-id-type="pmid">22134833</pub-id>
              </element-citation>
            </ref>
            <ref id="col4a1-dis.REF.meuwissen.2015.843">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Meuwissen</surname>
                    <given-names>ME</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Halley</surname>
                    <given-names>DJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Smit</surname>
                    <given-names>LS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lequin</surname>
                    <given-names>MH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cobben</surname>
                    <given-names>JM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>de Coo</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>van Harssel</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sallevelt</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Woldringh</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>van der Knaap</surname>
                    <given-names>MS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>de Vries</surname>
                    <given-names>LS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mancini</surname>
                    <given-names>GM</given-names>
                  </name>
                </person-group>
                <year>2015</year>
                <article-title>The expanding phenotype of COL4A1 and COL4A2 mutations: clinical data on 13 newly identified families and a review of the literature.</article-title>
                <source>Genet Med</source>
                <volume>17</volume>
                <fpage>843</fpage>
                <lpage>53</lpage>
                <pub-id pub-id-type="pmid">25719457</pub-id>
              </element-citation>
            </ref>
            <ref id="col4a1-dis.REF.ophoff.2001.447">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Ophoff</surname>
                    <given-names>RA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>DeYoung</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Service</surname>
                    <given-names>SK</given-names>
                  </name>
                </person-group>
                <year>2001</year>
                <article-title>Hereditary vascular retinopathy, cerebrovascular vasculopathy, and hereditary endotheliopathy with retinopathy, nephropathy, and stroke map to a single locus on chromosome 3p21.1-p21.3</article-title>
                <source>Am J Hum Genet</source>
                <volume>69</volume>
                <fpage>447</fpage>
                <lpage>53</lpage>
                <pub-id pub-id-type="pmid">11438888</pub-id>
              </element-citation>
            </ref>
            <ref id="col4a1-dis.REF.plaisier.2010.2550">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Plaisier</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chen</surname>
                    <given-names>Z</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gekeler</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Benhassine</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dahan</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Marro</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Alamowitch</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Paques</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ronco</surname>
                    <given-names>P</given-names>
                  </name>
                </person-group>
                <year>2010</year>
                <article-title>Novel COL4A1 mutations associated with HANAC syndrome: a role for the triple helical CB3[IV] domain.</article-title>
                <source>Am J Med Genet A.</source>
                <volume>152A</volume>
                <fpage>2550</fpage>
                <lpage>5</lpage>
                <pub-id pub-id-type="pmid">20818663</pub-id>
              </element-citation>
            </ref>
            <ref id="col4a1-dis.REF.plaisier.2007.2687">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Plaisier</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gribouval</surname>
                    <given-names>O</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Alamowitch</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mougenot</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Prost</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Verpont</surname>
                    <given-names>MC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Marro</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Desmettre</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cohen</surname>
                    <given-names>SY</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Roullet</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dracon</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fardeau</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Van Agtmael</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kerjaschki</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Antignac</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ronco</surname>
                    <given-names>P</given-names>
                  </name>
                </person-group>
                <article-title>COL4A1 mutations and hereditary angiopathy, nephropathy, aneurysms, and muscle cramps.</article-title>
                <source>N Engl J Med.</source>
                <year>2007</year>
                <volume>357</volume>
                <fpage>2687</fpage>
                <lpage>95</lpage>
                <pub-id pub-id-type="pmid">18160688</pub-id>
              </element-citation>
            </ref>
            <ref id="col4a1-dis.REF.richards.2007.1068">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Richards</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>van den Maagdenberg</surname>
                    <given-names>AM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jen</surname>
                    <given-names>JC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kavanagh</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bertram</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Spitzer</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Liszewski</surname>
                    <given-names>MK</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Barilla-Labarca</surname>
                    <given-names>ML</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Terwindt</surname>
                    <given-names>GM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kasai</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>McLellan</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Grand</surname>
                    <given-names>MG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vanmolkot</surname>
                    <given-names>KR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>de Vries</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wan</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kane</surname>
                    <given-names>MJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mamsa</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schafer</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Stam</surname>
                    <given-names>AH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Haan</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>de Jong</surname>
                    <given-names>PT</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Storimans</surname>
                    <given-names>CW</given-names>
                  </name>
                  <name name-style="western">
                    <surname>van Schooneveld</surname>
                    <given-names>MJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Oosterhuis</surname>
                    <given-names>JA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gschwendter</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dichgans</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kotschet</surname>
                    <given-names>KE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hodgkinson</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hardy</surname>
                    <given-names>TA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Delatycki</surname>
                    <given-names>MB</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hajj-Ali</surname>
                    <given-names>RA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kothari</surname>
                    <given-names>PH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nelson</surname>
                    <given-names>SF</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Frants</surname>
                    <given-names>RR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Baloh</surname>
                    <given-names>RW</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ferrari</surname>
                    <given-names>MD</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Atkinson</surname>
                    <given-names>JP</given-names>
                  </name>
                </person-group>
                <year>2007</year>
                <article-title>C-terminal truncations in human 3'-5' DNA exonuclease TREX1 cause autosomal dominant retinal vasculopathy with cerebral leukodystrophy.</article-title>
                <source>Nat Genet</source>
                <volume>39</volume>
                <fpage>1068</fpage>
                <lpage>70</lpage>
                <pub-id pub-id-type="pmid">17660820</pub-id>
              </element-citation>
            </ref>
            <ref id="col4a1-dis.REF.r_dahl.2013.946">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>R&#x000f8;dahl</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Knappskog</surname>
                    <given-names>PM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Majewski</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Johansson</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Telstad</surname>
                    <given-names>W</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kr&#x000e5;kenes</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Boman</surname>
                    <given-names>H</given-names>
                  </name>
                </person-group>
                <year>2013</year>
                <article-title>Variants of anterior segment dysgenesis and cerebral involvement in a large family with a novel COL4A1 mutation.</article-title>
                <source>Am J Ophthalmol</source>
                <volume>155</volume>
                <fpage>946</fpage>
                <lpage>53</lpage>
                <pub-id pub-id-type="pmid">23394911</pub-id>
              </element-citation>
            </ref>
            <ref id="col4a1-dis.REF.shah.2012.569">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Shah</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ellard</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kneen</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lim</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Osborne</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rankin</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Stoodley</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>van der Knaap</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Whitney</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jardine</surname>
                    <given-names>P</given-names>
                  </name>
                </person-group>
                <year>2012</year>
                <article-title>Childhood presentation of COL4A1 mutations.</article-title>
                <source>Dev Med Child Neurol</source>
                <volume>54</volume>
                <fpage>569</fpage>
                <lpage>74</lpage>
                <pub-id pub-id-type="pmid">22574627</pub-id>
              </element-citation>
            </ref>
            <ref id="col4a1-dis.REF.shah.2010.182">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Shah</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kumar</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>McLean</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Churchill</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Stoodley</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rankin</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rizzu</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>van der Knaap</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jardine</surname>
                    <given-names>P.</given-names>
                  </name>
                </person-group>
                <article-title>A dominantly inherited mutation in collagen IV A1 (COL4A1) causing childhood onset stroke without porencephaly.</article-title>
                <source>Eur J Paediatr Neurol.</source>
                <year>2010</year>
                <volume>14</volume>
                <fpage>182</fpage>
                <lpage>7</lpage>
                <pub-id pub-id-type="pmid">19477666</pub-id>
              </element-citation>
            </ref>
            <ref id="col4a1-dis.REF.sibon.2007.177">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Sibon</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Coupry</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Menegon</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bouchet</surname>
                    <given-names>JP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gorry</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Burgelin</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Calvas</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Orignac</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dousset</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lacombe</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Orgogozo</surname>
                    <given-names>JM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Arveiler</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Goizet</surname>
                    <given-names>C</given-names>
                  </name>
                </person-group>
                <year>2007</year>
                <article-title>COL4A1 mutation in Axenfeld-Rieger anomaly with leukoencephalopathy and stroke.</article-title>
                <source>Ann Neurol</source>
                <volume>62</volume>
                <fpage>177</fpage>
                <lpage>84</lpage>
                <pub-id pub-id-type="pmid">17696175</pub-id>
              </element-citation>
            </ref>
            <ref id="col4a1-dis.REF.vahedi.2007.1461">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Vahedi</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kubi</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Boukobza</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Arnoult</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Massin</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gould</surname>
                    <given-names>DB</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tournier-Lasserve</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bousser</surname>
                    <given-names>MG</given-names>
                  </name>
                </person-group>
                <year>2007</year>
                <article-title>COL4A1 mutation in patient with sporadic recurrent intracerebral hemorrhage.</article-title>
                <source>Stroke</source>
                <volume>38</volume>
                <fpage>1461</fpage>
                <lpage>4</lpage>
                <pub-id pub-id-type="pmid">17379824</pub-id>
              </element-citation>
            </ref>
            <ref id="col4a1-dis.REF.van_der_knaap.2006.504">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>van der Knaap</surname>
                    <given-names>MS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Smit</surname>
                    <given-names>LM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Barkhof</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pijnenburg</surname>
                    <given-names>YA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zweegman</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Niessen</surname>
                    <given-names>HW</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Imhof</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Heutink</surname>
                    <given-names>P</given-names>
                  </name>
                </person-group>
                <year>2006</year>
                <article-title>Neonatal porencephaly and adult stroke related to mutations in collagen IV A1.</article-title>
                <source>Ann Neurol</source>
                <volume>59</volume>
                <fpage>504</fpage>
                <lpage>11</lpage>
                <pub-id pub-id-type="pmid">16374828</pub-id>
              </element-citation>
            </ref>
            <ref id="col4a1-dis.REF.verbeek.2012.844">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Verbeek</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Meuwissen</surname>
                    <given-names>ME</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Verheijen</surname>
                    <given-names>FW</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Govaert</surname>
                    <given-names>PP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Licht</surname>
                    <given-names>DJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kuo</surname>
                    <given-names>DS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Poulton</surname>
                    <given-names>CJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schot</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lequin</surname>
                    <given-names>MH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dudink</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Halley</surname>
                    <given-names>DJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>de Coo</surname>
                    <given-names>RI</given-names>
                  </name>
                  <name name-style="western">
                    <surname>den Hollander</surname>
                    <given-names>JC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Oegema</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gould</surname>
                    <given-names>DB</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mancini</surname>
                    <given-names>GM</given-names>
                  </name>
                </person-group>
                <year>2012</year>
                <article-title>COL4A2 mutation associated with familial porencephaly and small-vessel disease.</article-title>
                <source>Eur J Hum Genet</source>
                <volume>20</volume>
                <fpage>844</fpage>
                <lpage>51</lpage>
                <pub-id pub-id-type="pmid">22333902</pub-id>
              </element-citation>
            </ref>
            <ref id="col4a1-dis.REF.xia.2014.97">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Xia</surname>
                    <given-names>XY</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Li</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cao</surname>
                    <given-names>X</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wu</surname>
                    <given-names>QY</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Li</surname>
                    <given-names>TF</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zhang</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Li</surname>
                    <given-names>WW</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cui</surname>
                    <given-names>YX</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Li</surname>
                    <given-names>XJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Xue</surname>
                    <given-names>CY</given-names>
                  </name>
                </person-group>
                <year>2014</year>
                <article-title>A novel COL4A1 gene mutation results in autosomal dominant non-syndromic congenital cataract in a Chinese family.</article-title>
                <source>BMC Med Genet</source>
                <volume>15</volume>
                <fpage>97</fpage>
                <pub-id pub-id-type="pmid">25124159</pub-id>
              </element-citation>
            </ref>
            <ref id="col4a1-dis.REF.yoneda.2012.86">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Yoneda</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Haginoya</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Arai</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Yamaoka</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tsurusaki</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Doi</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Miyake</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Yokochi</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Osaka</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kato</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Matsumoto</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Saitsu</surname>
                    <given-names>H</given-names>
                  </name>
                </person-group>
                <year>2012</year>
                <article-title>De novo and inherited mutations in COL4A2, encoding the type IV collagen &#x003b1;2 chain cause porencephaly.</article-title>
                <source>Am J Hum Genet</source>
                <volume>90</volume>
                <fpage>86</fpage>
                <lpage>90</lpage>
                <pub-id pub-id-type="pmid">22209246</pub-id>
              </element-citation>
            </ref>
            <ref id="col4a1-dis.REF.yoneda.2013.48">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Yoneda</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Haginoya</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kato</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Osaka</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Yokochi</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Arai</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kakita</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Yamamoto</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Otsuki</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Shimizu</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wada</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Koyama</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mino</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kondo</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Takahashi</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hirabayashi</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Takanashi</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Okumura</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kumagai</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hirai</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nabetani</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Saitoh</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hattori</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Yamasaki</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kumakura</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sugo</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nishiyama</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Miyatake</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tsurusaki</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Doi</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Miyake</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Matsumoto</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Saitsu</surname>
                    <given-names>H</given-names>
                  </name>
                </person-group>
                <year>2013</year>
                <article-title>Phenotypic spectrum of COL4A1 mutations: porencephaly to schizencephaly.</article-title>
                <source>Ann Neurol</source>
                <volume>73</volume>
                <fpage>48</fpage>
                <lpage>57</lpage>
                <pub-id pub-id-type="pmid">23225343</pub-id>
              </element-citation>
            </ref>
            <ref id="col4a1-dis.REF.zenteno.2014.1789">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Zenteno</surname>
                    <given-names>JC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Crespi</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Buentello-Volante</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Buil</surname>
                    <given-names>JA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bassaganyas</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vela-Segarra</surname>
                    <given-names>JI</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Diaz-Cascjosa</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Marieges</surname>
                    <given-names>MT</given-names>
                  </name>
                </person-group>
                <article-title>Next generation sequencing uncovers a missense mutation in COL4A1 as the cause of familial retinal arteriolar tortuosity.</article-title>
                <source>Graefes Arch Clin Exp Ophthalmol</source>
                <year>2014</year>
                <volume>252</volume>
                <fpage>1789</fpage>
                <lpage>94</lpage>
                <pub-id pub-id-type="pmid">25228067</pub-id>
              </element-citation>
            </ref>
          </ref-list>
        </sec>
        <sec id="col4a1-dis.Suggested_Reading">
          <title>Suggested Reading</title>
          <ref-list id="col4a1-dis.Suggested_Reading.reflist0">
            <ref id="col4a1-dis.REF.flossmann.2006.131">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Flossmann</surname>
                    <given-names>E</given-names>
                  </name>
                </person-group>
                <year>2006</year>
                <article-title>Genetics of ischaemic stroke; single gene disorders.</article-title>
                <source>Int J Stroke</source>
                <volume>1</volume>
                <fpage>131</fpage>
                <lpage>9</lpage>
                <pub-id pub-id-type="pmid">18706033</pub-id>
              </element-citation>
            </ref>
            <ref id="col4a1-dis.REF.lanfranconi.2010.e513">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Lanfranconi</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Markus</surname>
                    <given-names>HS</given-names>
                  </name>
                </person-group>
                <year>2010</year>
                <article-title>COL4A1 mutations as a monogenic cause of cerebral small vessel disease: a systematic review.</article-title>
                <source>Stroke.</source>
                <volume>41</volume>
                <fpage>e513</fpage>
                <lpage>8</lpage>
                <pub-id pub-id-type="pmid">20558831</pub-id>
              </element-citation>
            </ref>
            <ref id="col4a1-dis.REF.mine.2009.1">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Mine</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tournier-Lasserve</surname>
                    <given-names>E</given-names>
                  </name>
                </person-group>
                <year>2009</year>
                <article-title>Intracerebral hemorrhage and COL4A1 mutations, from preterm infants to adult patients.</article-title>
                <source>Ann Neurol</source>
                <volume>65</volume>
                <fpage>1</fpage>
                <lpage>2</lpage>
                <pub-id pub-id-type="pmid">19194872</pub-id>
              </element-citation>
            </ref>
          </ref-list>
        </sec>
      </sec>
      <sec id="col4a1-dis.Chapter_Notes">
        <title>Chapter Notes</title>
        <sec id="col4a1-dis.Revision_History">
          <title>Revision History</title>
          <list list-type="bullet">
            <list-item>
              <p>7 July 2016 (ha) Comprehensive update posted live</p>
            </list-item>
            <list-item>
              <p>8 March 2011 (me) Comprehensive update posted live</p>
            </list-item>
            <list-item>
              <p>25 June 2009 (et) Review posted live</p>
            </list-item>
            <list-item>
              <p>27 February 2009 (ep) Original submission</p>
            </list-item>
          </list>
        </sec>
      </sec>
      <sec sec-type="figs-and-tables">
        <title/>
        <fig position="float" id="col4a1-dis.F1" orientation="portrait">
          <label>Figure 1. </label>
          <caption>
            <p>Spectrum of brain imaging abnormalities in <italic toggle="yes">COL4A1</italic>-related disordersA. Axial FLAIR showing right paraventricular porencephalic cyst and extensive white-matter abnormalities [<xref ref-type="bibr" rid="col4a1-dis.REF.van_der_knaap.2006.504">van der Knaap et al 2006</xref>]B. Axial FLAIR showing diffuse periventricular leukoencephalopathy and dilated perivascular space in the basal ganglia [<xref ref-type="bibr" rid="col4a1-dis.REF.vahedi.2007.1461">Vahedi et al 2007</xref>]C. Deep intracerebral hemorrhage [<xref ref-type="bibr" rid="col4a1-dis.REF.vahedi.2007.1461">Vahedi et al 2007</xref>]D. Angio CT scan in a patient with HANAC syndrome showing two aneurysms located in the intracranial portion of the right carotid artery [<xref ref-type="bibr" rid="col4a1-dis.REF.plaisier.2007.2687">Plaisier et al 2007</xref>]</p>
          </caption>
          <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="col4a1-dis-Image001" position="anchor" orientation="portrait"/>
        </fig>
        <fig position="float" id="col4a1-dis.F2" orientation="portrait">
          <label>Figure 2. </label>
          <caption>
            <p>Abdominal MRI showing bilateral renal cysts in a patient with HANAC syndrome [<xref ref-type="bibr" rid="col4a1-dis.REF.plaisier.2007.2687">Plaisier et al 2007</xref>]</p>
          </caption>
          <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="col4a1-dis-Image002" position="anchor" orientation="portrait"/>
        </fig>
        <fig position="float" id="col4a1-dis.F3" orientation="portrait">
          <label>Figure 3. </label>
          <caption>
            <p>Fluorescein angiography. Typical retinal arteriolar tortuosity (arrows) in a patient with HANAC syndrome [<xref ref-type="bibr" rid="col4a1-dis.REF.plaisier.2007.2687">Plaisier et al 2007</xref>].</p>
          </caption>
          <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="col4a1-dis-Image003" position="anchor" orientation="portrait"/>
        </fig>
      </sec>
    </body>
  </book-part>
</book-part-wrapper>
